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F plasmid TraI (192 kD) is essential for DNA transfer during bacterial 
conjugation. TraI is composed of a relaxase domain, ssDNA binding domain, helicase 
domain, and C-terminal domain. Some TraI mutants, created by the Traxler lab, have 
a 31 AA insertion (i31) in different domains that exhibit higher mating efficiencies 
than wild-type (WT) TraI.  We used a live cell SeqA-YFP fusion protein system to 
investigate the observed higher mating efficiency. DNA appeared earlier in the 
recipient in the i31 mutants compared to WT, and the change was not due to a 
difference in second strand synthesis. To investigate where the transfer process is 
altered, we employed a TraI fusion protein system to determine if altering the stability 
of a protein inserted within the i31 of the TraI mutants would alter mating efficiency.  
Utilizing TraI-YFP cloned into the i31 sites, we created YFP point mutants 
with altered stability, G67A and I161A. Mating efficiency is reduced when YFP is 
inserted into TraI. However, when the YFP chromophore is destabilized (G67A), or a 
hydrophobic cluster is altered (161A) mating efficiency recovers to near i31 levels. 
These data indicate that altering the stability of the protein can affect transfer 
efficiency. These data also suggest that altered stability may play a role in producing 
the i31 phenotype. To investigate the stability and folding of the i31 mutants, a region 
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of TraI (309-858) containing various i31 insertion points were cloned and expressed. 
These fragments were analyzed by circular dichroism and chemical titration 
denaturation to determine the ∆G of unfolding for each fragment. There were no 
significant differences in the ∆G values, however subtle differences in the data are 
consistent with stability playing a role for the increased mating efficiency for i681. 
These data also indicate the increased mating efficiency seen for all the i31 mutants 
analyzed may have multiple different causes, the nature of which is dependent on the 
location of the insertion. 
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Antibiotics were first widely used during World War II, and their use in 
treating wounds and ulcers dramatically changed the outcomes for many gravely 
wounded soldiers (Waksman, 1947). Injuries that once would have proved fatal due 
to infection were now survivable. Use in hospitals skyrocketed, and they were seen as 
a cure-all for any infection. Over time however, infections that were once easily 
treated with standard antibiotics started to become resistant and they became much 
harder to successfully treat.  
Evolution of antibiotic resistance genes in various microbes has become a 
huge problem in the field of medicine. Antibiotic resistance has become a prominent 
modern medical issue due to overuse of antibiotics since their discovery (Levy, 2002). 
Every year, more and more hospitals spend increasing amounts of money to treat 
hospital-acquired infections, which are often multi-drug resistant. This problem is 
only being compounded by over prescription of antibiotics and patients taking those 
antibiotics improperly, creating bacteria with drug resistances that can pass those 
resistances to pathogenic bacteria. The occurrence of multi-drug resistant bacteria in 
recent years has had a high medical and human cost (Centers for Disease Control, 
2013).  
The process that passes the resistance genes from one bacterial cell to another 
is known as horizontal gene transfer. Horizontal gene transfer occurs through multiple 
methods, one of which is the process of bacterial conjugation. In bacterial conjugation,  
a bacterial cell containing a mobile genetic element finds a cell without that mobile 
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genetic element, and begins transferring the mobile genetic element from one cell to 
the other. The donor cell passes a single strand of DNA through a pore complex into 
the recipient cell, and following second strand synthesis the recipient cell either 
incorporates the newly acquired DNA into its genome or maintains the element as a 
separate element (Willetts, 1972). DNA passed from a donor cell to a recipient cell 
can then be passed vertically to its progeny, potentially conferring to this cell line 
evolutionary advantages such as antibiotic resistance or the ability to utilize a new 
metabolite.  
Bacterial conjugation is accomplished through a complex of proteins known 
as the relaxosome. The roles of many of these proteins is known, but there are still 
parts of the process that we known little about. It is important to analyze these 
proteins, as they may give insight into how to halt this process on a molecular level 
and develop new strategies to treat infections. One of these relaxosome proteins, TraI, 
is responsible for many steps in the process of conjugation. We know parts of its 
structure and its functions, but how it is regulated or how it interacts with other 
components is still being investigated. Gaining a more complete understanding of 
TraI is crucial to fully describing bacterial conjugation and its role in the process. In 
this introduction the components of the relaxosome, their structures and functions, are 
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The Relaxosome 
A mobile genetic element, F plasmid, is a 100 kb long single copy plasmid 
found in Escherichia coli (E. coli). F plasmid contains within it most of the genes 
necessary for transfer in a region known as the tra operon (Zechner et al., 2000). This 
region contains the tra and trb gene clusters, which encode a series of genes required 
for conjugation. F plasmid also has an origin of replication (oriV) and an origin of 
transfer (oriT). The oriT is the position where a group of proteins known as the 
relaxosome bind and nick the DNA in preparation for transfer of a single strand of 
DNA (known as the T strand) from cell to cell (Willetts, 1972).  
The relaxosome is a protein complex composed of Integration Host Factor 
(IHF), TraY, TraM and TraI, all encoded by F plasmid except for IHF. IHF is 
encoded by the host genome. TraY and IHF are necessary for creating the correct 
architecture required for TraI to nick and unwind F plasmid. These proteins bind 
within a region of the F plasmid known as the oriT. The oriT region contains protein 
binding sites as well as structural elements necessary for the binding and nicking of 
the DNA by TraI (Figure 1.1). Organizationally, the nic site is located on the bottom 
DNA strand and the structural elements and protein binding sites are all located 5’ to 










Figure 1.1. Adapted from Williams and Schildbach, 2007, the organization of the 
oriT region of F plasmid. In light blue is the sbi site where TraI binds oriT. In green 
are the IHF binding sites, and in dark blue are the sbm binding sites, which are bound 
by TraM. The sbyA site in purple is bound by TraY. The binding of the oriT region by 
TraY and IHF bends the DNA and gives TraI access to the single stranded nic site, 
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Integration Host Factor 
Detailing the components of the relaxosome, IHF is a small heterodimer 
consisting of two 10 kDa subunits that are closely related to HU, a nonspecific DNA 
binding protein. HU proteins and members of that family of proteins have been found 
in many prokaryotes (Oberto and Rouviere-Yaniv, 1996). IHF binds at the oriT site 
ihfA and creates a 160˚ bend in the DNA, reversing the direction of the helix axis by 
binding at the minor groove of DNA (Williams and Schildbach, 2007, Rice et al., 
1996). As seen in the crystal structure of IHF (Figure 1.2), the dimer bends the DNA 
by over 160 degrees, reversing the direction of the helix axis. It is able to bend the 
DNA so drastically due to a proline residue that interrupts the base stacking by 
intercalating into the DNA. IHF also binds at the lower affinity ihfB site, but it is not 
necessary for nicking of F plasmid (Fu et al., 1991). IHF identifies its binding site by 
indirect readout, which is recognition of a sequence dependent alteration in the 
conformation of DNA. In the IHF binding site, there is a six base run of adenine that 
narrows the minor groove, which IHF is able to identify. The binding of IHF creates 
two large kinks in the DNA, bending it around IHF (Rice et al., 1996). This bending 
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Figure 1.2. Crystal structure of integration host factor (IHF) in green from E. coli 
bound to DNA. IHF depicted as its backbone cartoon structure, and DNA as its 
cartoon structure (backbone in orange). The DNA is wrapped around the protein, 
bending it by over 160 degrees by interrupting base stacking by an intercalating 
proline (not pictured). Structure generated in PyMOL from PDB entry 1IHF, 
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TraY 
Also participating in the relaxosome, TraY is a site specific double stranded 
DNA binding protein (Karl et al., 2001, Luo et al., 1994). There is no crystal 
structure of TraY, but it is monomeric and has been classified in the ribbon-helix-
helix motif (RHH) family of proteins. It contains tandem repeats of this motif, which 
is unusual (Schildbach et al., 1998). TraY binds at sybA located 5’ of the nic site and 
further bends the DNA, allowing TraI to access its binding site sbi and nick the DNA 
at the nic site (Nelson et al., 1995, Williams and Schildbach, 2007). The binding site 
of TraY, sbyA, consists of three subsites, two of which are bound cooperatively. 
These two sites contain imperfect inverted GA(G/T)A repeats, while the third site is 
direct repeat (Lum et al., 2002). Inserting sequence between its binding site sbyA and 
the binding site of IHF, ihfA, drastically reduces plasmid mobilization (Williams and 
Schildbach, 2007). In addition to binding the oriT region to promote the nicking 
reaction, TraY also plays a role in regulating gene expression of the transfer region 
(Silverman and Scholl, 1996). After TraY and IHF have created the correct DNA 
architecture for TraI, it can bind to the oriT DNA and carry out its function in the 
relaxosome complex.  
 
TraM 
While not required for the cleavage of oriT  and not involved in creating the 
architectural elements TraI requires to carry out its role in conjugation, TraM is 
required for conjugation. TraM is thought to interact with TraD to bring the 
relaxosome complex into proximity with the transfer machinery. It does this by 
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binding at the sbmA, B, and C sites in the oriT (Achtman et al., 1971, Lu et al., 2008). 
TraM may also interact with TraI to enhance the activity of TraI and the nicking 
reaction (Ragonese et al., 2007). TraM is a small tetrameric DNA binding protein. It 
recognizes its high affinity binding site, sbmA, as a dimer of tetramers. The crystal 
structure from plasmid pED208, an F-like plasmid, was recently solved and gave 
insight into the role of TraM in the relaxosome complex (Figure 1.3) (Wong et al., 
2011). TraM contains an N-terminal ribbon-helix-helix (RHH) motif that binds DNA 
in a staggered arrangement that allows for DNA binding without any direct contact 
between the tetramers. The tetramers of TraM target the sequence motif of GANTC 
12 bp apart within sbmA. Each tetramer targets a pair of these sequence motifs by 
coordinated kinking and unwinding of the DNA to align the motifs on the same side 
of the helix. This allows for the C-terminal tetramerization domain of TraM to remain 
free, and the tetramerization domain can interact with TraD. TraD is the pore 
coupling protein, and the interaction between the tetramerization domain and TraD 
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Figure 1.3. The crystal structure of the asymmetric unit of TraM bound to ssDNA. 
Each monomer of the tetramer is colored separately. The N terminal domain of TraM 
(closest to the ssDNA strand) interacts with the ssDNA, while the C-terminal 
tetramerization domain remains free of DNA contacts to interact with TraD. Structure 
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TraI 
The protein central to the relaxosome, TraI is a multiple domain protein that 
carries out different functions during conjugation. TraI is a 1756 amino acid long 192 
kD single-chain protein, possessing four distinct domains. TraI has an N-terminal 
relaxase (nickase) domain encoded in the first 300 amino acids, a single-stranded 
DNA binding domain extending from residue 300 to 822, a helicase domain 
encompassing residues 980 to 1500, and a 200 amino acid C-terminal domain (Figure 
1.4)(Traxler and Minkley Jr, 1988, Wright et al., 2012, Dostal and Schildbach, 2010). 
The relaxase domain recognizes the nic site and cuts a single strand of F plasmid. The 
recognition of the oriT and the nic site by TraI is highly sequence specific for an 11 
bp region of oriT, and a single base substitution in that region can reduce the affinity 
of TraI for a ssDNA oligonucleotide containing the oriT sequence by as much as 
8000-fold (Stern and Schildbach, 2001). Substitutions between bases 140' and 141' in 
the oriT sequence (numbering as defined by the Frost lab) reduce affinity by at least 














Figure 1.4. A, TraI consists of four domains (from left), a relaxase domain; non-
specific single stranded DNA binding domain, a helicase domain, and a C-terminal 
domain. Parts of the structure of TraI have been solved as seen above, but sections of 
TraI (depicted by yellow boxes) are lacking specific structural data. Each domain 
carries out a different function during the mating process, with the relaxase domain 
binding to the oriT of F plasmid and nicking the DNA at the nic site. The helicase 
domain acts to unwind the DNA for transfer of a single strand to the recipient cell. 
The C-terminal domain is thought to be involved in interactions with the pore 
complex. B, a schematic representation of TraI, including the four domains, the 
locations of the two translocation (TS) sequences, and the positions of the i31 
mutations within TraI.  
	  
Relaxase domain             non-specific ssDNA binding domain         Helicase domain          C-terminal 
domain    
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TraI Nicking Reaction 
The nicking reaction is a key step in conjugation, and the details of the 
reaction are key to understanding the importance of TraI. Once TraY and IHF have 
assembled on their binding sites at the oriT, TraI binds at the sbi site and locates the 
nic site. TraI nicks the DNA via a Mg+2 dependent nucleophilic attack at a tyrosyl 
hydroxyl oxygen on a DNA phosphate at nic. The attack at the oxygen leads to a 
covalent tyrosinyl-DNA bond between the DNA and Tyr16 of TraI that is 
isoenergetic and reversible (Street et al., 2003). The 5’ end of the F plasmid DNA is 
bound to TraI in a long-lived intermediate (Byrd and Matson, 1997). TraI, bound to 
DNA, is transferred from donor to recipient through a type IV secretion system pore. 
Once transferred through the pore, the nicking reaction is reversed and the DNA is 
recircularized. Once the plasmid DNA has been recircularized, second strand 
synthesis occurs, and the cell receiving the plasmid now contains a double-stranded 
copy of the plasmid (Dostal and Schildbach, 2011, Lang et al., 2010).  
 
TraI Relaxase Domain 
The activity of each domain is important to the overall function of TraI in 
conjugation. The relaxase domain of TraI contains a His-hydrophobe-His (HUH) 
motif in its active site. These histidine residues in the active site are part of a three 
histidine cluster that bind a divalent cation (as stated above) that is required for the 
cleavage of oriT. Substitutions for the histidine residues were found to alter the 
binding of the metal ion, indicating their role in the binding site (Larkin et al., 2007). 
	   13	  
TraI can utilize various metals to coordinate the nic reaction, and is able to use Mg2+ 
and Mn2+ at millimolar and micromolar concentrations respectively (Datta et al., 
2003). This metal binding motif aids in the binding and nicking of ssDNA by 
positioning the DNA and increasing the positive charge on the phosphorus of the 
DNA backbone to enhance the nucleophilic attack by the other active site residue 
crucial to the reaction, Tyr16 (Larkin et al., 2005, Dostal et al., 2011). Tyr16 is 
required for the nic reaction, as the nucleophilic reaction covalently links the 
hydroxyl oxygen of Tyr16 to the 5ʹ′ end of the DNA (Dostal et al., 2011).  
 
Non specific ssDNA Binding Domain 
The ssDNA binding domain is located between residues 300 and 822. The 
ssDNA binding domain region resembles RecD, but does not possess any ATPase 
activity (Wright et al., 2012). The ssDNA binding domain competes with the relaxase 
domain for DNA binding, meaning when one domain is occupied it prevents the other 
from binding (Dostal and Schildbach, 2010). The ssDNA binding domain displays 
sequence specificity and binds ssDNA with high affinity. The negative cooperativity 
between domains is believed to be part of the regulation of the timing of transfer of F 
plasmid (Dostal and Schildbach, 2010).  
 
Helicase Domain and Translocation Sequences 
Once the DNA is cut and bound to the relaxase domain, the helicase domain 
functions to unwind the DNA in a 5ʹ′ to 3ʹ′ manner (Lang et al., 2010, Dostal and 
Schildbach, 2011). TraI contains within the single stranded DNA binding domain and 
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the helicase domain two regions, called translocation sequences (TS) that function as 
pore recognition sequences. In the conjugative model system plasmid R1, interaction 
between a domain of TraD (T4CP) and TraI have been demonstrated to be necessary 
for initiation of transfer through the pore (Mihajlovic et al., 2009, Sut et al., 2009). 
The translocation sequences TSA (amino acids 530-816) and TSB (1255-1564) in 
plasmid R1 target the relaxosome complex to the secretion pore (Lang et al., 2010, 
Redzej et al., 2013). TraI from plasmid R1 and TraI from F plasmid are highly 
homologous, and although the translocation sequences for F plasmid TraI have not 
been investigated, due to the sequence homology the translocation signals are most 
likely in the same regions.  
 
C-terminal Domain 
The C-terminal domain is comprised of the last 200 amino acids of TraI. The 
C-terminal domain may be necessary for interaction with TraM. TraM, as previously 
described, is part of the relaxosome and interacts with TraD to bring the relaxosome 
to the transfer machinery and may also interact with TraI through its C-terminal 
domain (Lu et al., 2008, Ragonese et al., 2007). Part of the structure of the C-terminal 
domain has been solved, which will be detailed in the next section (Guogas et al., 
2009). 
 
Structure of TraI 
The overall structure of TraI has been difficult to determine, as sections of the 
protein are disordered and x-ray crystallography or nuclear magnetic resolution 
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spectroscopy (NMR) of the entire protein are not possible. The structures of sections 
of TraI have been solved, including the relaxase domain, part of the single stranded 
DNA binding domain, and part of the C-terminal domain, but the full structure is still 
unsolved. Having already detailed the activities of the domains of TraI, the structure 
is no less important to understanding the full role of TraI. 
The structure of the relaxase domain gave insight into the structure of the 
active site of the relaxase, and helped to identify the active site residues and the 
mechanism by which TraI cleaves the oriT (Figure 1.5)(Larkin et al., 2007). Since the 
structure of the relaxase was solved, other sections of TraI have been crystallized or 
analyzed by NMR to obtain structural data. The solution of the NMR structure of 
residues 381-569 provided insight into the domain organization of this region. The 
structure closely resembles a RecD domain, although there is no ATPase activity 
present in this domain (Figure 1.6)(Wright et al., 2012). The structure of part of the 
C-terminal domain has been solved, giving insight into its role in conjugation (Figure 
1.8)(Guogas et al., 2009). Most recently, the structure of R1 TraI from 575 to 786 
was solved, which includes the Translocation A (TSA) sequence (Figure 1.7). Like 
the structure of the N-terminal section of the ssDNA binding domain (Figure 1.6), 
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Figure 1.5. The relaxase domain of TraI, generated in PyMOL from PDB entry 1P4D 
from Datta et al., 2003. The relaxase uses a metal ion (in yellow), coordinated by the 
His-hydrophobe-His (HUH) cluster (in magenta) in the active site to position the nic 
site DNA for Tyr16 (in orange), which performs a nucleophilic attack at a tyrosyl 
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Figure 1.6. TraI 381-569, part of the ssDNA-binding domain, similar to RecD, from 
PDB entry 2L8B. Image generated in PyMOL from Wright et al., 2012, the single 
stranded DNA binding domain is thought to compete for DNA binding with the 
relaxase domain and prevent TraI from nicking. The negative cooperativity between 
the ssDNA binding domain and the relaxase domain is thought to be a major regulator 
of F plasmid transfer.  
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Figure 1.7. The TSA region of TraI, generated from PDB entry 4L0J in PyMOL from 
Redzej et al., 2013, displayed as a cartoon structure. The TSA region contains 
specific residues, A593 (orange), D714 (yellow), S739 (magenta), and T746 (white), 
which are thought to make specific contacts with the pore coupling protein, TraD. 
These residues, shown as a stick models, define an interaction surface in the TSA of 
the protein.  
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Figure 1.8. The C-terminal domain of TraI generated in PyMOL, shown in green, 
PDB entry 3FLD, from Guogas et al., 2009. The C-terminal domain of TraI is 
thought to play a role in recruitment of the relaxosome to the pore complex through 
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The amino acid sequence of the TSA of R1 TraI is nearly identical to F TraI, 
with only a two-residue difference between the two in the region of 575 to 786. The 
structure of this domain is therefore similar to the domain in F TraI. The structure of 
this domain aided in identifying residues within the TSA that are crucial for 
translocation. The TSA comprises the region of amino acids 530 – 816. The second 
translocation sequence, the TSB, is located closer to the C-terminus of the protein, in 
between residues 1255 and 1564. Only one of these translocation sequences is 
required for transfer of the protein (Lang et al., 2011).  
Using the structure and previous research, Redzej et al., were able to 
determine that residues 593, 714, 736, and 739 play an important role in the transport 
of R1 TraI from donor to recipient (Redzej et al., 2013). These residues, which are 
identical in F TraI, may also play an important role in F TraI and these recent 
structures give increasing insight into the function of TraI. Although a full structure 
has not been solved, an envelope structure of the protein has been developed using 
small angle x-ray scattering (SAXS), indicating an elongated conformation in 
solution (Cheng et al., 2011). Recent work on calculating the solution structure of 
TraI by modeling simulations have generally agreed with the envelope structure of 
TraI determined by Cheng et al., 2011. These structures generally predict that TraI 
folds into a compact molecule despite the unstructured regions (Clark et al., 2014). 
The TraI protein from F plasmid belongs to a large family of TraI and TraI-
like relaxase proteins from mobilizable plasmids across incompatibility groups. The 
relaxases from the various groups share functionality (nicking ssDNA), but are highly 
divergent in general sequence and organization. In the IncF group, the relaxases 
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generally consist of the N-terminal relaxase domain, a C-terminal helicase domain, 
and a C-terminal domain involved in plasmid transfer (Garcillan-Barcia et al., 2009). 
In other groups, the proteins can look quite different and be of varying sizes, but they 




During the mating process, TraI is transported along with DNA from one cell 
to another (Dostal et al., 2011, Willetts, 1972). It is widely accepted that TraI will 
pass through the conjugative pore on its way to the recipient, but the pore structure 
has a main ring structure with a cap that has a 20 Å opening to the pore exit (Fronzes 
et al., 2009). While there is likely some rearrangement of the pore structure to 
increase the diameter of the pore to allow exit of substrate from the pore into the 
recipient cell, even with mechanical force the folded structure of TraI would probably 
not transit the pore successfully. Moreover, TraI undergoes some degree of unfolding 
to transit the pore structure into the recipient cell. Many further studies on other 
protein translocation systems have investigated the forces necessary for protein 
translocation, and unfolding of protein substrate. For example, Eilers and Schatz 
discovered that mitochondrial pre-proteins that are folded before transport into the 
mitochondria must unfold for transport through the membrane (Eilers and Schatz, 
1986). The mechanical principles behind protein unfolding are universal across all 
systems. Although most work on protein unfolding during transport has been 
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conducted in eukaryotic systems, there is ample precedent for protein unfolding being 
necessary for transport across a membrane in prokaryotes. 
Having described the relaxosome in detail, another important part of the 
transfer machinery is the pore. The relaxosome and its components function to 
transport ssDNA from one cell to another, and to get from one cell to another a pore 
is required. Understanding the pore and its structure is crucial to fully understanding 
the transport process. In the next section, the type of pore that is used by F and F like 
plasmids is described.  
 
Type IV Secretion Systems 
As large as TraI is, it is able to pass through a type IV secretion system pore 
(T4SS) along with the T strand DNA it is covalently bound to (Juhas et al., 2008). 
Both Gram negative and Gram positive bacteria use type IV secretion systems for the 
transfer of mobile genetic elements. Type IV secretion systems are versatile systems 
capable of transporting substrates of various types and size, including known 
relaxases MobA and VirD2 (Vergunst et al., 2005, Ninio and Roy, 2007). There are 
at least six known secretion systems used by Gram negative bacteria to secrete a 
variety of factors into the environment and other cells (Alvarez-Martinez and Christie, 
2009). The various types of secretion systems can be further broken down into sub-
categories. The F plasmid uses the T4SS IVA to transport plasmid DNA and protein 
during bacterial conjugation. This system resembles the T4SS in Agrobacterium 
tumefaciens, the VirB/D4 pore system. The VirB/D4 is one of the most well studied 
T4SS, and many parallels between the F plasmid T4SS and the VirB/D4 systems can 
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be drawn to illuminate F plasmid and TraI transfer during conjugation (Christie et al., 
2005). Other type IVA systems include those in RP4 (IncP), R388 (IncW), and 
pKM101 (IncN) as well as F plasmid (IncF) (Juhas et al., 2008, Christie et al., 2005). 
Only recently has the structure of a type IV pore been solved. The structure of 
the type IV pore from the plasmid pKM101 was solved at 15 Å by cryo-EM, and 
recently refined to 8.5 Å (Fronzes et al., 2009, Rivera-Calzada et al., 2013). A higher 
resolution structure of the outer membrane portion of the pore complex was solved by 
crystallography at a resolution of 2.6 Å (Chandran et al., 2009). These structures have 
given insight into the structure and organization of the pore complex (Figures 1.9 and 
1.10). The genes encoding the proteins that comprise the pore complex are usually 
located in a single operon or group of operons, and are highly related within the T4SS 
IVA systems. The VirB/D4 transfer system is composed of 12 proteins, VirB1-
VirB11 and VirD4.  The F plasmid encodes eight T4SS subunits homologous to 
subunits in the VirB/D4 complex, as well as subunits only found in the T4SS used by 
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Figure 1.9. The structure of the O-layer of the pore complex from pKM101, as seen 
from the top down, generated in PyMOL from PDB entry 3ZBI, deposited by Rivera-
Calzada et al., 2013. In green is TraN, in orange is TraF, and in blue is TraO. These 
proteins (14 copies of each) form a ring structure with a cap that has a 10 Å 
constriction. TraF forms the interior of the outer layer of the pore, while TraO forms 
the outer sheath of the pore. TraF acts as a signal transmitter through the entire pore, 
interacting with the ATPases and propagating conformational changes by ATP 
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Figure 1.10. A side view of the structure of the O-layer of the pore complex from 
pKM101, as seen from the top down, generated in Pymol from PDB entry 3ZBI, 
deposited by Rivera-Calzada et al., 2013. In green is TraN, in orange is TraF, and in 
blue is TraO. Here we can more clearly see how TraF extends from the cap structure 
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Type IV secretion system complexes span both the inner and outer 
membranes. In the structures reported in Fronzes et al., 2009 and Chandran et al., 
2009, the core complex is a 1.07 megadalton structure comprising VirB7, VirB9, and 
VirB10 (in pKM101, these are TraN, TraO, and TraF respectively). The whole core 
complex measures approximately 185 Å from top to bottom and from side to side. 
The core complex is comprised of 14 copies of each protein, with the structure 
divided into an inner (I) layer inserted into the inner membrane, and an outer (O) 
layer inserted into the outer membrane of the bacteria (Figure 1.10). The I layer is 
composed of the N-terminal domains of TraO and TraF. The O layer consists of TraN 
and the C-terminal domains of TraO and TraF, creating a main ring structure with a 
cap that has a 20 Å opening and a 10 Å constriction ( Fronzes et al., 2009). The 
diameter of the constriction varies, as the crystallography structure reports a 
constriction of 20 Å, indicating the structure of the core complex is flexible. The 
diameter of dsDNA is ~20 Å, and although only ssDNA is being transported, the 
diameter of ssDNA in addition to protein as they are transferred through the pore is 
more than likely larger than 10 Å. There is probably some movement within the cap 
region of the pore to widen its diameter and allow the passage of substrate from one 
cell to another, but unfolding of the protein substrate is also possibly required 
(Chandran et al., 2009, Mandelkern et al., 1981). 
The cap of the pore is comprised of TraN only, created by a hydrophobic ring 
of 2-helix bundles. TraO and TraF surround the inner TraN ring. The inner membrane 
channel is likely formed by three proteins; VirB3, VirB6, and VirB8 (Cascales and 
Christie, 2004). Three ATPases power secretion through the pore complex, VirB4, 
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VirB11, and VirD4. These ATPases, acting in concert with one another, form a 
complex on the cytoplasmic face of the pore and provides the energy for the 
translocation of substrate through the pore (Waksman and Fronzes, 2010). The F 
plasmid encodes most of the core T4SS components, including genes for pilus and 
pore formation (Lawley et al., 2003). Before these recent structures the exact details 
of the T4SS pore were not well understood. The general structure of a pore used in a 
conjugative process is now known, giving us insight into what F plasmid DNA and 
TraI might pass through on its way into the recipient. The various T4SS used by 
different species of bacteria all provide similar functionality (Tseng et al., 2009). In 
addition to the pore structure, the pilus is an important part of the transfer machinery 
involved in identifying potential mating targets. In the next section the F pilus is 
described to give a deeper understanding of the mating machinery.  
 
F Pilus 
As part of the pore structure and the translocation machinery, conjugative 
plasmids encode proteins that form a pilus structure on the cell surface. In E. coli, a 
donor cell (F+) will extend a pilus to recognize a recipient cell (F-). Once an F- cell is 
identified by the pilus, the F+ cell initiates mating pair formation (Mpf) and mating 
pair stabilization (Mps). It is not entirely clear how the pilus identifies an F- recipient, 
but it is thought to be either an interaction between lipopolysaccharides or a negative 
charge on the cell surface (Frost et al., 1994, Hazes and Frost, 2008). After Mps and 
the identification of the F- recipient by the F+ donor, an unknown signal is transmitted 
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to the donor to begin the process of transferring the F plasmid DNA to the recipient 
through the T4SS-like pore (Frost et al., 1994). 
The F pilus is composed solely of the F plasmid encoded pilin protein. F 
plasmid pili can be up to 20 µm long, and have an outside diameter from 85Å to 95 Å 
and a central lumen of approximately 2-3 nm (Lawn, 1966). The F pilus is classified 
as a thick flexible pili, involved in both Mpf and Mps (Bradley, 1980). The F pilus is 
made up entirely of pilin, encoded by the traA gene (Frost et al., 1984). Pilin is a 
small 70 residue protein that is largely α-helical in structure. Before it is incorporated 
into the pilus structure, the traA product is processed to mature pilin. A 51 amino acid 
signal sequence must be removed, and the amino acid terminus of the remaining 
protein is acetylated (Frost et al., 1984). The traA product is processed by TraQ, 
which cleaves the 51 amino acid signal sequence, and TraX, which performs the 
acetylation of the amino terminus (Maneewannakul et al., 1993). Finally, plasmid 
incompatibility groups are important for understanding plasmid inheritance. 
 
Plasmid Incompatibility Groups 
Using the pili, a F+ cell identifies an F- cell to transfer the plasmid. Both Gram 
negative and Gram positive bacteria contain plasmids. Plasmids can be transferred 
from one cell to another of the same species and across species. However, the 
transferred plasmid is not always retained and is often not kept by the cell; the 
plasmid is not stability inherited. This can be due to the presence of another plasmid 
already in the cell. The plasmid that is already present is unable to stably coexist with 
the new plasmid, and it destabilizes the inheritance of the second plasmid. This 
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phenomenon of lack of stable inheritance is known as plasmid incompatibility, which 
occurs when the plasmids present in a cell contain the same origin of replication and 
are competing for replication factors (Novick, 1987). Plasmids have been divided and 
categorized into various incompatibility groups, with F and F-like plasmids being 
grouped into the IncF group. These plasmids are generally repressed for transfer by 
the FinOP system, with mating events occurring about once for every thousand cells 
(Boyd and Hartl, 1997). The structure and function of TraI, the relaxosome 
components, the pore structure, and details on bacterial conjugation have been 
presented to give a full understanding of the mating process.  
Altering the proteins involved in the relaxosome and the transfer of F plasmid 
can alter the mating process. For example, knocking out the ATPase activity of TraI 
eliminates the transfer of DNA (Dostal et al., 2011). There are TraI mutants that can 
increase or decrease mating efficiency, depending on where the mutation occurs. 
These strains are known as the i31 collection. 
 
i31 E. coli strains 
How F plasmid is regulated for transfer is only partially understood, and the 
role TraI plays in this regulation is not completely defined. There is a cost to bacteria 
for maintaining a plasmid, as there is a limited amount of energy available for 
replication. There is a cost to expressing a gene, and while gene replication only 
accounts for 2% of the energy used by a cell, gene translation (protein synthesis) 
takes up 75% of a cell’s energy (Harold, 1986). If a cell suddenly has an increase in 
the number of genes, say from a plasmid, the energy cost increases. This puts 
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pressure on the cell, and creates a cost to the plasmid that can lead to destabilization 
of the inheritance of the plasmid, despite potential benefits the plasmid might have 
conveyed. Many conjugative plasmids carry a system that inhibits their horizontal 
transfer (fin) due to plasmid costs to the host cell. The fin system self-represses the 
conjugative transfer of that plasmid. When a conjugative plasmid’s fin system is 
removed, the plasmid becomes more costly to the cell, and although a fin- plasmid 
spreads more quickly, the plasmid is subsequently replaced by fin+ plasmids (Haft et 
al., 2009). 
To maintain and transfer only a single copy of F plasmid, the transfer process 
is highly regulated. TraI itself has negative feedback mechanisms and recognition 
motifs. There is negative cooperativity between the relaxase domain and the single 
stranded DNA binding domain, and within the ssDNA binding domain and the 
helicase domain are two pore-signaling translocation sequences (Zechner et al., 2010, 
and Dostal and Schildbach, 2010). However, it is not known exactly how these 
mechanisms act on DNA transfer. To better understand the DNA transfer in the 
conjugative process, we set out to use novel methods to probe TraI mutants. The TraI 
mutants that were used primarily in this study were TraI i31 mutants previously 
created by the Traxler lab and published in Haft et al., 2006.  
In that study, they used a transposon mutagenesis screen (lambdaTnlacZ/in 
system) to create in-frame small 31 amino acid scars (Manoil et al., 1997, Manoil et 
al., 2000). The i31 insertion includes a unique cloning site, a BamHI site that can be 
used for cloning DNA encoding small peptides or proteins into TraI. They found that 
insertions in certain regions of the protein were not only tolerated, but that the mutant 
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TraI proteins facilitated transfer with a mating efficiency increased over that of wild-
type (WT) TraI on the same vector (Haft et al., 2006). They postulated that the 
increase in mating efficiency could be due to the insertions releasing the protein from 
some sort of negative regulation of transfer (Haft et al., 2006). However, the 
mechanism by which the release from negative regulation was achieved was not 
determined. Here we aim to use a SeqA-YFP reporter system to better understand the 
relationship between DNA transfer and the TraI mutants. This system utilizes a 




The protein SeqA is an integral part of bacterial chromosomal replication 
timing. The indication of a replication timing mechanism was first published by 
Russell and Zinder in 1987, when they discovered that cells that lack a dam adenine 
methylase could not be efficiently transformed by methylated oriC containing 
plasmids. However, when these cells were transformed by unmethylated plasmids 
containing an oriC, transformation efficiency was restored. This indicated that the 
methylation status of DNA was important for oriC initiation (Russell and Zinder, 
1987). Further investigation by various researchers into the components of the 
replication timing mechanism eventually led to the discovery of the protein SeqA. 
SeqA forms part of the timing mechanism that prevents reinitiation of the oriC (Lu et 
al., 1994). DNA binding by SeqA sequesters the oriC for approximately one third of 
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the replication process. Along with other control mechanisms, this prevents the 
premature re-initiation of the oriC (Lu et al., 1994, Campbell and Kleckner, 1990).  
SeqA binds at both methylated and hemimethylated GATC sites within DNA. 
It preferentially binds hemimethylated DNA, with a KD in the nm range (Brendler and 
Austin, 1999). A dimer of SeqA binds the oriC to prevent reinitiation after it is 
initiated by DnaA (Skarstad and Boye, 1994). Binding of SeqA to DNA is 
cooperative, with a Hill Coefficient of 4.7 (Skarstad et al., 2000). SeqA requires 
multiple GATC sites spaced 5 - 34 bases apart to bind and form an oligomer that will 
sequester the site. The E. coli oriC has such an arrangement of GATC sites, (Figure 
1.11) and no other site on the chromosome has such an arrangement (Oka et al., 
1980). The oriC is about 245 base pairs in length with both DnaA targeting sequences 
and GATC sites targeted by SeqA (Oka et al, 1980, Asada et al., 1982). 
SeqA is 181 amino acids long and has two domains, an N-terminal 
oligomerization domain, and a C-terminal DNA binding domain (Figure 1.12). The 
first 50 residues comprise the oligomerization domain, and residues 51-181 comprise 
the DNA binding domain (Guarne et al., 2002). The oligomerization domain 
(residues 1 - 33) folds into two α-helices and one β-sheet. Residues 34 - 63 form a 
flexible linker between the oligomerization domain and DNA binding domain, and is 
responsible for the ability to bind GATC sequences up to 34 base pairs apart (Guarne 
et al., 2005, Brendler and Austin, 1999). Residues 64 - 181 fold into a small three-
strand antiparallel beta sheet, and seven alpha helices (Figure 1.12) (Guarne et al., 
2002).  
 







Figure 1.11. The oriC of E. coli, about 245 bases long, has a distinct arrangement of 
GATC sites (yellow ovals) that SeqA bind to sequester the oriC to prevent reinitiation. 
The GATC sites in the cluster are located within 34 bp of each other, as SeqA cannot 
bind and form an aggregate if they are farther apart. We found that F plasmid has a 
similar arrangement of GATC sites that would allow for SeqA binding and aggregate 







Arrangement of GATC sites within the oriC of E. coli 




Figure 1.12. Adapted from the PDB entry 1IU3, The DNA binding domain of SeqA, 
residues 71 – 181, in complex with hemimethylated DNA. In green, represented in 
cartoon format, are two DNA binding domains from two SeqA molecules bound to 
DNA (cartoon format). In order to form an aggregate, GATC sites on the DNA need 
to be situated close together for the N-terminal dimerization domains of SeqA to bind. 
A flexible linker connects the DNA binding domain and dimerization domains, and 
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SeqA binds DNA as a dimer, and oligomerization occurs by multimerization 
of the dimers. This creates a left-handed helical filament with each dimer turned 90 
degrees to the previous one (Guarne et al., 2005). The SeqA filaments can form large 
aggregates that sequester the DNA it is bound to due to the cooperativity of binding, 
and requires at least 6 GATC sites in close proximity to stabilize the aggregate (Han 
et al., 2003). This is important for sequestering the oriC during replication, as this 
aggregate physically blocks DnaA from reinitializing the oriC. Without the 
dimerization domain, SeqA binding would not be able to block DnaA. SeqA was 
recently used as a reporter in a new type of mating assay that utilizes the protein in 
live cell fluorescent microscopy (Babic et al., 2008). 
 
Traditional Mating Assays 
Fluorescence microscopy is a powerful tool for studying single molecule 
interactions, sub-cellular structures, and many other cellular processes. Recently, it 
has been used to create an assay for tracking DNA transfer in mating bacterial cells 
(Babic et al., 2008).  There are many advantages of a microscopy-based assay over 
traditional plate based assays. Bacterial mating assays have traditionally been plate 
based, analyzing the frequency of transfer of a reportable marker, most often 
antibiotic resistance genes. These assays are reliable indicators of plasmid transfer 
and establishment, but they are an assay of the end product of the conjugative process. 
They do not indicate whether a plasmid can be transferred but not established in a cell, 
and they only show the presence of a bacterial colony that has acquired a new marker. 
A real time assay that can track DNA transfer would enable a better understanding of 
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the conjugative process. Such a system was described in Babic et al., 2008, where 
they created a SeqA-YFP fusion protein under native promoter control. This allowed 
them to directly visualize DNA transfer in real time in a high frequency of 
recombination (Hfr) E. coli strain (Babic et al., 2008).  
In their work, they described the development of the SeqA-YFP system and 
what they were able to use the system to investigate. They were specifically interested 
in the role of the F pilus during conjugation, the fate of the transferred DNA, and the 
pattern of inheritance of donor DNA present in the initial transconjugate cell. Using 
their system, Babic and colleagues were able to visualize and quantify DNA as it was 
transferred from one cell to another, and to watch the acquisition of stable genomic 
information through recombination. This system operates in the recipient cell, where 
they created a SeqA-YFP fusion protein to allow for visualization of transferred DNA. 
When DNA is transferred, SeqA-YFP binds to the DNA after second strand synthesis, 
and forms a fluorescent focus that can easily be detected (Babic et al., 2008).  
SeqA not only binds to the oriC, but also binds at other hemi-methylated 
GATC sites and plays a role in gene expression (Guarne et al., 2005). This suggests 
that the SeqA-YFP system developed by Babic et al., 2008 could be used to track not 
just Hfr transfer, but F plasmid transfer as well. Analysis of F plasmid 
(NC_002483.1) reveals portions of F plasmid contain the required number of GATC 
sites within the proximity needed to form an aggregate of SeqA. Thus, it may be 
possible to apply this system to visualizing F plasmid transfer. In addition to probing 
TraI function and regulation with a live cell microscopy system, the TraI i31 mutants 
can be used to probe aspects of TraI utilizing the i31 insertion itself.  
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Dihydrofolate Reductase 
It is not known to what degree the stability of TraI plays a role in bacterial 
conjugation. If TraI must partially or completely unfold to facilitate transfer through 
the conjugative pore, altering the stability of certain regions might affect the 
efficiency of transfer. There is no structural data on the full-length protein, and not 
much known about the elements of the protein that would lend themselves to the 
structure and stability of the protein. Therefore we decided to take advantage of 
TraI’s tolerance for inserted proteins to help address this question.  
A previous graduate student in the lab, Marijke Koppenol, had created a TraI-
YFP construct, with YFP inserted in the i31 at amino acid position 593. As previously 
stated, the i31 sequence contains a unique BamHI site that allows for constructs to be 
cloned into that site. The insertion of YFP does lower mating efficiency but it does 
not eliminate it completely. This led us to the idea of inserting another small protein, 
dihydrofolate reductase (DHFR) into TraI. Dihydrofolate reductase is a 22 kDa 
protein that is highly conserved across many mammalian species, and also found in 
prokaryotes (Smith et al., 1979). DHFR is a crucial enzyme, as it has a central role in 
DNA precursor synthesis. The first structure of DHFR was solved over thirty years 
ago, and many structures of DHFR from various species have subsequently been 
solved. It has a core beta sheet structure, usually consisting of an eight stranded beta 
sheet surrounded by four alpha helices (Figure 1.13). The protein possesses two 
subdomains separated by the active site, and substrate and cofactor bind at a deep 
hydrophobic cleft between domains. DHFR catalyzes the reduction of dihydrofolate 
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to tetrahydrofolate, utilizing NADPH as a cofactor for the reaction (Schnell et al., 
2004). The active site consists of conserved proline and tryptophan residues, the 
tryptophan being involved in substrate binding (Filman et al., 1982, Bolin et al., 
1982).  
When bound to its ligand, DHFR is resistant to mechanical unfolding and the 
thermodynamic stability of the protein is also altered (Ainavarapu et al., 2005, 
Wallace and Matthews, 2002). The mechanical stability of DHFR without bound 
ligands is quite low, around 27 pN. When bound to MTX however, the mechanical 
stability increases to 82 pN, nearly tripling the force required to unfold the protein 
(Ainavarapu et al., 2005). DHFR fusion proteins have also previously been used to 
study protein translocation across other membranes, such as the mitochondrial 
membrane (Eilers and Schatz, 1986). There have been numerous studies that suggest 
mitochondrial import motors function as a Brownian ratchet or are capable of 
mechanical work to import protein, and that mechanical unfolding is an essential step 
in protein translocation (Okamoto et al., 1998, Huang et al., 1999). These studies 
utilized DHFR and MTX to probe the translocation of protein to the mitochondria. 
When DHFR is bound to its natural substrates, the chemical stability of the protein is 
also altered; the midpoint of a urea titration shifts from 1.4 M to 2.8 M (Wallace and 
Matthews, 2002). DHFR exhibits increased stability when bound to its ligands, and 
this makes it an ideal candidate for studying protein stability and a good candidate for 
insertion into TraI.  
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Figure 1.13. Murine DHFR (in green), in complex with 2.4-diamino-6-(-2’-
hydroxybenz[b,f]azepin-5-yl) methyl pteridine (in pink), an inhibitor of DHFR like 
MTX. The structure was generated in PyMOL from the PDB entry 3D84, submitted 
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Dihydrofolate reductase has previously been used to study transport of 
proteins across membranes, and in those studies, murine DHFR was used. 
Dihydrofolate reductase from E. coli has a dissociation constant for the binding of 
methotrexate to DHFR of 9.5 nM and the affinity of MTX for DHFR is about 1000 
fold that of folate (Rajagopalan et al., 2002). In the presence of MTX, murine DHFR 
(mDHFR) fused to a mitochondrial presequence was blocked from entering the 
mitochondria (Eilers and Schatz, 1986, Esaki et al., 1999, Gehde et al., 2008). Since 
murine DHFR has previously been used to study protein translocation, it will be used 
for the study of protein stability with TraI. Use of a non-bacterial DHFR will also 
preclude the cell from potentially dying immediately upon introduction of MTX to 
the cell.  
 
Yellow Fluorescent Protein  
Yellow fluorescent protein is a protein often used as a reporter for 
fluorescence microscopy or as a report of protein expression. In the SeqA-YFP 
system, it has been fused to SeqA to report on DNA transfer (Babic et al., 2008). In 
addition to its use as a reporter, YFP has other qualities that make it amenable to 
other uses. Yellow fluorescent protein (YFP) is a derivative of green fluorescent 
protein, originally isolated from Aequorea victoria (Figure 1.14)(Shimomura et al., 
1962). Green fluorescent protein (GFP) is 238 amino acids long and 26.9 kDa 
(Prendergast and Mann, 1978). GFP has a major excitation peak at 395 nm, and a 
minor excitation peak at 475 nm. Its emission peak occurs at 509 nm, in the lower 
part of the green portion of the visible spectrum, which gives the protein its name and 
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distinctive characteristic (Johnson et al., 1962). Green fluorescent protein has been 
used as a reporter for many years, and over those years modified forms of the protein 
have been developed. GFP itself does not mature efficiently at 37˚C, or any other 
temperatures above those naturally experienced by A. victoria.  
Different versions of GFP were subsequently developed for further study of 
the protein and expanded laboratory use. The first major improvement was a single 
point mutant, S65T, which improved the spectral characteristics of the protein, the 
fluorescence intensity, and the photostability (Tsien et al., 1995). Another mutant, the 
F64L point mutant, increased folding efficiency at 37˚C and was dubbed enhanced 
GFP (eGFP) (Heim et al., 1995). Adding to these changes created spectral variants of 
GFP, one of those being Yellow Fluorescent Protein (YFP). YFP has an excitation 
peak at 514 nm, and an emission peak at 527 nm. The mutations M153T, V163A, and 
S175G around the chromophore are what cause the excitation and emission peak 
shifts. Along with the S65T mutation, one of the improved versions of YFP, mVenus 
also contains the F64L mutation, which accelerates the formation of the chromophore 
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Figure 1.14. Crystal structure of YFP generated in PyMOL from PDB entry 1YFP, 
submitted to the PDB by Watcher et al., 1998. The protein chain is colored as a 
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The stability of GFP and its derivatives have only recently been investigated. 
Once the chromophore of the molecule is formed, it is very stable and remains intact 
during protein unfolding. The reverse of the original folding reaction is not possible. 
However, if the chromophore is destabilized, folding of the protein becomes 
reversible. When one residue of the chromophore of GFP is mutated, G67A, the 
folding of the protein becomes largely reversible (Kutrowska et al., 2007). In addition 
to chemical stability, the mechanical stability of eYFP has been measured. It has two 
distinct unfolding peaks, one with a mean unfolding force of 69 +/- 23 pN, and the 
other with a mean unfolding force of 122 +/- 23 pN (Jimenez et al., 2006). YFP is not 
easily unfolded under native conditions, since the protein’s chromophore is highly 
resistant to unfolding. Since YFP is generally stable, that characteristic can be 
leveraged for investigating the stability of TraI.  
In addition to the G67A mutation, GFP was found to have two hydrophobic 
clusters on opposite sides of the protein. Melting of cycle-3 GFP and two of its 
mutants, I14A and I161A, reveal the protein most likely denatures in a three-stage 
process. The I161A mutant in particular destabilizes one of the hydrophobic clusters 
and creates a less stable unfolding intermediate (Melnik et al., 2011). Both of these 
stability mutations could be utilized for studying protein stability in TraI using the i31 
as the insertion point. In addition to using DHFR, YFP can be used to investigate the 
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Circular Dichroism 
We can use various protein insertions and mutants to analyze the function and 
regulation of TraI, but those methods are indirect as we are manipulating proteins 
within TraI. To get a more complete understanding of TraI, we can measure the 
stability of the protein itself. Circular dichroism (CD) has been a method used by 
structural biologists since the 1960s to examine protein structure and stability. 
Circular dichroism is the measurement of the unequal absorption of left-handed and 
right-handed circularly polarized light. Circular dichroism in the near UV spectrum is 
used to investigate the secondary structure of proteins since amino acids will give 
different signals depending on their optical transitions. The result of this difference in 
optical transitions is different characteristic spectra for the different structural 
elements. The α-helix has signal minima at 222 nm and 208 nm, and a maximum at 
193 nm, while β-helices produce a spectrum with a minimum at 218 nm and a 
maximum at 195 nm  (Holzwarth G, Doty P., 1965, Greenfield and Fasman, 1969). 
Proteins with disordered regions and random coil structures have low ellipticity above 
210 and a signal minimum near 195 nm (Venyaminov et al., 1993). These marked 
differences in signal can give a picture of the secondary structure of the protein, and 
these wavelengths can be used to monitor protein stability and unfolding.  
 
Objectives of the Thesis 
TraI is a complex, multidomain protein responsible for carrying out the 
nicking and unwinding of F plasmid during a mating event. While some of its 
structure has been determined, the regulation between the domains and the negative 
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cooperativity between the ssDNA binding domain and the relaxase domain is not well 
understood. We currently do not have a full understanding of this negative 
cooperativity and what can cause F plasmid transfer to become derepressed (as we 
see in some mutants of TraI). The Traxler group created the collection of i31 TraI 
mutants using transposon mutagenesis, which left behind 31 amino acids in TraI 
wherever the transposon had inserted (Haft et al., 2006). Some of these mutants had a 
mating efficiency well above that of WT TraI. They postulated that these 31 amino 
acid insertions were releasing TraI from some type of negative regulation, but no 
explanation of how that occurred was identified.  
Our lab examined some of the i31 mutants in more detail and discovered that 
they have reduced affinity for ssDNA and a reduction in the apparent negative 
cooperativity compared to WT TraI (Dostal and Schildbach, 2010). These results 
confirmed that negative cooperativity was an important factor in controlling mating 
and changing the frequency of mating events, but what exactly the i31 was causing to 
create the change in negative cooperativity was still unknown. The i31 sequence is 
apparently relatively unstructured, and some of the i31s in the mutants are inserted 
into structured regions. We asked why the insertion of an unstructured peptide 
increases mating efficiency and releases TraI from negative cooperativity. To answer 
this question, we employed a new technique for analyzing mating events, a live cell 
microscopy system that allows for visualization of DNA transfer in real time.  
Much of the research investigating transfer of mobile genetic elements has 
been done via assays that utilize transfer of a reportable marker from donor to 
recipient. This is a reliable method for determining if a plasmid transfers and 
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establishes itself in the recipient. This method however, has its drawbacks, as it is a 
measure of the end result of the transfer process. A newer method, which utilizes a 
fluorescent marker in the recipient cell, the SeqA-YFP system, has been developed 
which can be used for monitoring mating in a much narrower time window (Babic et 
al., 2008). Using this system, we obtained data that correlated with the previously 
published mating assay data, and indicated the i31 mutants not only had a higher 
mating efficiency, but transferred DNA appears more quickly in the recipient as well.  
After obtaining these data, we utilized unfolding studies and probed protein 
stability with proteins inserted into TraI to determine if the unstructured character of 
the i31 was changing the stability of TraI. We postulated this was the cause of the 
changes seen in the i31 mutants, but we did not see any gross changes in protein 
stability. Inserting proteins into TraI reduces mating efficiency, but when the inserted 
protein is destabilized, mating efficiency recovers. These data indicate TraI stability 
may play a role in conjugation. Although our direct stability measurements of TraI 
did not show any major changes, we did see small but consistent changes in stability 
of one of the i31 mutants. These data indicate stability may be playing a role in the 
phenotype of the i31 mutants, but at a local structural level and not a global one. Our 
data also indicate there is no global explanation of the i31 phenotype. In this work, 
we will demonstrate that the altered mating efficiency in the i31 mutants correlates 
with dsDNA appearing earlier in recipients when mated in the live cell SeqA-YFP 
system, and the possible causes of this phenotype.  
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CHAPTER 2 
MATERIALS AND METHODS 
 
Bacterial Strains and Plasmids 
Escherichia coli recipient strain BA24 was kindly provided by the Radman 
lab. Escherichia coli strains XK1502, XK1502 i369, i593, i681, and i1753 containing 
F plasmid with the traI gene substituted by tetracycline resistance cassette 
(XK1502/FΔTraI) were kindly provided by Prof. Beth Traxler (University of 
Washington, USA). All strains and plasmids are listed in tables 2.1, 2.2, and 2.3. 
 
Live Cell Fluorescence Microscopy Assay 
Mating and microscopy procedures were carried out according to a protocol 
adapted from the methods of Babic et al, 2008. Donor strains were grown in LB 
media containing ampicillin (100 µg/ml) to an OD600 of .6, and the recipient strain 
BA24 was grown to an OD600 of 0.9 in minimal media (M9 salts) supplemented with 
0.4% succinate, 0.1% CAA, 30 µg/ml thiamine, 3 mM MgSO4, 20 µg/ml uracil, and 
50 µg/ml of streptomycin. Donor strains all use the XK1502 (F- ∆lacU169 nalA) 
parent strain to carry various TraI mutants on plasmids (Haft et al., 2006). Once the 
recipient and donor strains reached the proper OD600, 1 ml of each was washed twice 
in minimal media (M9-) and resuspended in 1 ml of M9-. For real time mating under 
the microscope, cells were mixed in a 1:1 ratio, and plated on an agarose slab (1.5% 
agarose in M9-) in a temperature controlled live cell micro-observation chamber 
(Bioptechs) and transferred to the microscope for time lapse observation. 
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 Time-lapse microscopy was performed using an inverted microscope (IX-81, 
Olympus) with a 100X oil-immersion objective (Olympus). The sample was held at 
37˚C using cover slide and objective heaters (Bioptechs) and imaged with a 525 nm 
longpass filter (Chroma) and an emission filter (ET540x30m, Chroma). Fluorescent 
illumination was provided by the 514 nm line of an Innova Ion I-308 laser (Coherent) 
with an illumination power density of 1kW/cm2. Excitation light was filtered through 
a 514 nm laser line filter (Semrock). Images were taken through a cooled EM-CCD 
(Andor Ixon DU888), using an imaging algorithm built into Metamorph (Molecular 
Devices) imaging software. Using the algorithm, up to 10 cell clusters were imaged 
automatically every 3 minutes. Image analysis was performed using imageJ (NIH). 
 
Interrupted Mating Assay 
Cells were grown as previously described for the live cell microscopy mating 
assay. Prior to imaging on the microscope, cells were mixed in a 1:1 ratio and mated 
for a set time period. Mating was halted with vigorous vortexing and addition of 
0.01% sodium dodecyl sulfate (SDS). Cells were then plated on an agarose slab and 
imaged at 25˚C. 
 
Protein Purification  
Overnight cultures for TraI were inoculated from single colonies into LB 
containing 30 mg/mL kanamycin (LB-kan, Sigma). One liter of LB supplemented 
with 30 µg/ml kanamycin was inoculated with 1 mL of overnight culture and grown 
at 37˚C to an OD600 of 0.6. Protein expression was induced with Isopropyl β-D-1-
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thiogalactopyranoside (IPTG) (1 mM final concentration) (Thermo Scientific) and the 
culture was grown overnight at 20 ˚C. Cells were harvested, pelleted (15000 rpm, 30 
min, 4 ˚C) (Thermo Fisher), and stored at -80˚C. Cells were thawed at 4˚C and 
resuspended in buffer A (50 mM Tris pH 7.5, 50 mM NaCl, 1 mM EDTA) with 
protease inhibitor (Sigma). Cells were lysed by sonication, and the resulting product 
was spun down at 4˚C for 15 minutes at 15,000 rpm. Ammonium sulfate (30% v/v, 
MP Biomedicals) was added to the resulting supernatant, and spun down again for 1 
hour (4˚C, 15,000 rpm). The resulting pellet was resuspended in buffer A, and passed 
through a 0.45 micron filter (Millipore) prior to application of the sample to a 5 mL 
Heparin column (GE Life Sciences) equilibrated in buffer A. 
The sample was fractionated using a gradient from 50 mM NaCl to 1 M NaCl 
using an AKTA Prime Plus (GE Life Sciences) and elution was monitored by A280. 
Fractions containing protein were pooled and 3 M ammonium sulfate was added to a 
final concentration of 1 M. The sample was then applied to a 5 mL Phenyl column 
(GE Life Sciences) and fractionated using a gradient from 1 M ammonium sulfate to 
0 M. Fractions containing protein were assessed by SDS-gel electrophoresis and 
Coomassie staining, and the fractions were estimated to be more than 95% pure. The 
fractions were pooled and dialyzed overnight into buffer containing 100 mM NaCl, 
20 mM NaPO4 (pH 7.5), and 0.1 mM EDTA. The protein sample was concentrated 
using a Centricon (Amicon) concentrator to approximately 50-100 µg/mL. Protein 
samples were subsequently used in nicking assay experiments. 
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TraI Fragment Purification 
The TraI 309-858 fragments were purified as described above through 
fractionation using the heparin column. Fractions from the heparin column containing 
protein were pooled and dialyzed for 2 hours in buffer A, and then applied to a 5 mL 
Q column (GE Life Sciences) and a gradient from 50 mM NaCl to 1 M NaCl was run 
over the column. For the i593 and wild type + i31 fragments, an additional phenyl 
column (as described above) was run after the Q column to improve purity. The 
protein samples were dialyzed overnight into buffer containing 20 mM NaPO4 pH 7.4, 
0.1 mM EDTA, and 100 mM NaCl. Protein samples were concentrated as above and 
the concentration of each sample was determined by guanidine denaturation. Protein 
was diluted into 7.5 M guanidine HCl and 25 mM NaPO4 pH 6.5, and the absorbance 
of the protein at 280 nm was determined. The absorbance measurement was used to 
determine concentration by the Beer-Lambert equation (Edlehoch, 1967). Circular 
dichroism (CD) experiments were performed with the protein samples.  
 
Nicking Assay  
Purified full length TraI and TraI i31 mutants were diluted to 1 µM stock for 
use in all nicking assays. The protein was diluted to 100 nM final concentration in 
each assay. The protein, oligo (Cy5 oriT, 20 nM, IDT) and buffer (20 mM MgCl2, 
100 mM NaCl, 40 mM Tris pH 7.5) were mixed to a total volume of 18 µL and 
incubated at 37˚C for a set amount of time. The reaction was halted with the addition 
of 2 µL proteinase K (20 mg/mL, to final concentration of 2 mg/mL). To the reaction 
mix, 21 µL formamide was added and incubated at 95 ˚C for 5 minutes. The reaction 
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mix was run on a 16 % polyacrylamide 8 M urea gel, 20 V per cm, with each well 
containing 20 µL of reaction mix. Gels was run for one hour and fifteen minutes, then 
imaged on a Typhoon 9410 Variable Mode Imager (GE Healthcare) using excitation 
at 648 nm and emission at 668 nm. 
 
Circular Dichroism 
Circular dichroism experiments were carried out similarly to methods used in 
Street et al., 2003. Unfolding and refolding experiments were conducted using urea as 
denaturant. Thermal denaturation of the TraI 309-858 fragment was found to be 
irreversible. An Aviv model 420 Circular Dichroism spectrometer was used for all 
CD measurements. After running an initial wavelength scan of 2 µM wild-type TraI 
309-858, it was determined the structure was primarily α-helical and all subsequent 
unfolding experiments could be measured at 222 nm. For wavelength experiments, 
protein was diluted in buffer (20 mM NaPO4 pH 7.4, 0.1 mM EDTA, and 100 mM 
NaCl) to either 5 µM or 10 µM and scanned from 350 nm to 195 nm with scans every 
1 nm and measured for an averaging time of 5 seconds. For denaturation experiments, 
2 µM solutions of wild-type TraI 309-858 (or i31 mutants) were made in both 0 M 
urea and 8.0 M urea. The change in ellipticity was monitored in a cuvette at 25˚C by 
removing a set amount of solution from the cuvette and adding in the appropriate 
amount of titrant by an automated titrator (Aviv). Solutions were allowed to stir 
together for 6 minutes and the ellipticity at 222 nm was averaged for 30 seconds. 
Initial experimentation with the wild type 309-858 fragment over a wide range of 
urea concentrations indicated TraI 309-858 was fully unfolded at a urea concentration 
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of 3M. The range of urea concentrations to test was optimized to 0 to 4.5M, with 
0.2M steps. Urea denaturation was found to be reversible and the data fit into a two 
state transition model between native and denatured states. The data was fit with a 







XK1502 F∆TraI with p99i-TraI (and various TraI mutants created from p99i-
TraI) was used as the donor strain. GM124 (streptomycin resistant) was used as the 
recipient in all plate based mating assays. Both donor and recipient were grown 
overnight in LB plus appropriate antibiotics. The overnight culture was diluted 
1:1000 into fresh LB and grown to an OD600 of 0.45. Donor and recipient cells were 
mixed in a 1:10 ratio (donor to recipient) with 100 µL of donor being mixed with 900 
µL of recipient. The donor/recipient mix was incubated for 1 hour at 37˚C and 
vortexed vigorously for 30 seconds to break apart mating pairs. The sample was 
chilled on ice for 10 minutes and a serial dilution series of the sample was made and 
plated onto LB-agar. Transconjugates were selected for on LB-agar plates containing 
25 µg/mL tetracycline and 50 µg/mL streptomycin (LB-tet/strep) while donors were 
selected for on LB-agar plates with 25 µg/mL tetracycline and 100 µg/mL ampicillin 
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(LB-tet/amp). Efficiency of the mating was calculated as the number of 
transconjugates per donor. 
 
Mating Assays with Methotrexate 
Mating assays were carried out as described above, with additional steps to 
add in methotrexate (MTX). MTX was made in a 50 mM stock solution, filter 
sterilized, and appropriate amounts were added to each mating assay. Prior to mixing 
the donor and recipient, both donor and recipient cells were spun down to remove the 
media. Media containing 50 µM MTX was added to the cells, the cells were 
resuspended in the MTX containing media, and incubated at room temperature for 15 
minutes prior to mixing donor and recipient. Cells were mixed in a 1:10 ratio, mated 
for 60 minutes, and spun down after mating to remove any remaining MTX from the 
reaction before plating. Cells were mated in either no MTX (0 nM) or 50 µM MTX.   
 
DNA Transformation  
50 µL of cells was mixed with 1.5 µL of plasmid DNA and incubated on ice 
for 30 minutes. Cells were heat shocked at 42˚C for 45 seconds and allowed to 
recover on ice for 10 minutes. LB (950 µL) was added to the tubes and cells were 
incubated for outgrowth for an hour in a 37˚C shaker incubator (New Brunswick 
Scientific). The cells (50 µL - 250 µL) were plated on LB-agar containing the 
appropriate antibiotic and incubated at 37˚C overnight. Single colonies were picked 
and miniprepped for confirmation of clones by DNA sequencing (Genewiz). 
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TraI-DHFR Construction 
Using TraI cloned into the p99 plasmid (p99i), mDHFR (pCMV-sport6 
mdhfr) was inserted at various permissive sites (369, 593, 681, 1753, which refer to 
the amino acid position) within TraI. These positions on TraI have previously had a 
BamHI site (in frame) cloned into TraI via the i31 insertion library. The DHFR gene 
used in this cloning is mdhfr cloned into pCMV-sport6 (American Type Culture 
Collection). The gene was PCR amplified from pCMV-sport6 (Table 2.2). The gene 
plus engineered BamHI sites were cloned into pNEB193, allowing for easy 
manipulation. Using this construct, the mDHFR gene was cut with BamHI, ligated 
with p99i variants and transformed into XK1502 cells. The p99i-mDHFR fusion 
protein plasmids were purified and successful insertion of mDHFR was confirmed by 
sequencing and expression test. Any successful transfer can only be due to the p99i-
mDHFR plasmid that has been transformed into the strain. These strains can be used 





DNA was prepped and purified by phenol/chlorform (Invitrogen) and ethanol 
precipitation due to the large size of the plasmids used for cloning (over 10 kb). 
Restriction enzymes were obtained from New England Biolabs. DNA fragments for 
cloning were amplified with Taq polymerase (New England Biolabs). Plasmid 
pZH007 containing mVenus (Zhao Lab), and i31 TraI mutants were prepped and 
purified, and mVenus was PCR amplified from pZH007 (see table for primers, 
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primers purchased from Integrated DNA Technologies). The PCR product was 
confirmed by DNA agarose gel electrophoresis (Biorad). Both the mVenus PCR 
product and p99i-TraI 593 were digested with BamHI for 2 hours at 37˚C. The 
plasmid and PCR product were precipitated with phenol/chlorform to purify the cut 
DNA. PCR product and plasmid were ligated together with T4 DNA ligase (New 
England Biolabs) for one hour at room temperature. Ligation reactions were 
transformed into chemically competent XL-1 Blue E. coli. Colonies were selected for 
on LB-agar plates containing ampicillin (100 µg/mL). Single colonies were grown 
out in LB-amp, and DNA was prepped and purified by phenol/cholorform 
precipitation and sent for sequencing to confirm the correct insertion of the mVenus 
PCR product. This cloning strategy was used for all subsequent cloning of mVenus 
into TraI.  
 
TraI Fragment Cloning 
Plasmid DNA and PCR product were prepped as described above. The 
fragments were PCR amplified from p99i-TraI with added NdeI and XhoI sites (Table 
2.2). PCR product for TraI 309-858 and pET24a was digested with NdeI and XhoI for 
2 hours at 37˚C (New England Biolabs). The pET24a plasmid was incubated with 
Calf Intestinal Phosphotase (CIP) (New England Biolabs) for 1 hour at 37˚C before 
phenol/chloroform extraction to remove the CIP. The PCR product and plasmid were 
ligated together and transformed as above, and colonies were screened for the insert 
via sequencing and expression test.  
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Quikchange Mutagenesis 
Quikchange mutagenesis was performed according to the Quikchange 
mutagenesis protocol by Stratagene. Template plasmid DNA was combined with 
mutagenesis primers, dNTPs (Fermentas), ddH2O, Pfu Turbo buffer and Pfu Turbo 
DNA polymerase (Agilent). After PCR amplification of the plasmid, the sample was 
incubated with DpnI (New England Biolabs) for 1 hour at 37˚C to remove the 
template. Additional Dpn I was added to the sample and incubated for another hour at 
37˚C. Dpn I was inactivated at 80˚C for 20 minutes prior to transformation. Mutant 
plasmids were generated from p99i-TraI and substitutions were analyzed and 
confirmed via DNA sequencing (Genewiz). 
 
 
Protein Expression Test 
To confirm correct cloning of plasmid constructs, expression tests were 
conducted. Overnight cultures for each construct were inoculated from single 
colonies into LB containing appropriate antibiotics. One 5 mL of culture with 
appropriate antibiotics was inoculated with 50 µL of overnight culture and grown at 
37˚C to an OD600 of 0.6. Protein expression was induced with Isopropyl β-D-1-
thiogalactopyranoside (IPTG) (1 mM final concentration) (Thermo Scientific) and 
incubated at 37˚C for three hours. From each culture, 40 µL of cells was pelleted by 
centrifugation, resuspended in loading buffer, and assessed by SDS-gel 
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Plasmid Description Reference/ 
Source 
p99I pTrc99A with wild-type traI cloned into the 
MCS 
Traxler Lab, 
Haft et al., 2006 
p99I-i369 pTrc99A with i369 mutant traI cloned into the 
MCS 
Traxler Lab, 
Haft et al., 2006 
p99I-i593 pTrc99A with i593 mutant traI cloned into the 
MCS 
Traxler Lab, 
Haft et al., 2006 
p99I-i681 pTrc99A with i681 mutant traI cloned into the 
MCS 
Traxler Lab, 
Haft et al., 2006 
p99I-i1753 pTrc99A with i1753 mutant traI cloned into 
the MCS 
Traxler Lab, 
Haft et al., 2006 
pZH007 Vector containing mVenus Xiao Lab 
pET24a Kanr cloning vector Schildbach Lab 
TraI WT + i31 
309-858 
pD441-SR with WT 309-858 + i31 DNA 2.0 
pCMV-Sport6 
mdhfr 
pCMV-Sport6 with mdhfr cDNA ATCC 
 
 
Table 2.1 The p99i plasmids used in this study, and plasmids obtained from other 
sources. All p99i plasmids contain TraI with a 31 amino acid transposon mutagenesis 
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pZH007 Vector containing mVenus Xiao Lab 
p99I-i369-YFP pTrc99A with i369 mutant traI with mVenus 
inserted at the i31 into TraI 
This study 
p99I-i593-YFP pTrc99A with i593 mutant traI with mVenus 
inserted at the i31 into TraI 
This study 
p99I-i681- YFP pTrc99A with i681 mutant traI with mVenus 




pTrc99A with i369 mutant traI with mdhfr 




pTrc99A with i681 mutant traI with mdhfr 




pET24a with TraI 309-858 cloned into the 
MCS 
This study 
pET24a TraI - 
i369 309-858 
pET24a with TraI i369 309-858 cloned into 
the MCS 
This study 
pET24a TraI – 
i593 309-858 
pET24a with TraI i593 309-858 cloned into 
the MCS 
This study 
pET24a TraI – 
i681 309-858 






pTrc99A with i593 mutant traI with mVenus 
inserted at the i31 with one of the following 





pTrc99A with i681 mutant traI with mVenus 
inserted into traI at the i31 with one of the 





pTrc99A with wild type TraI with one of the 












E. coli strains   
XK1502 F- ∆lacU169 nalA Traxler Lab 
Haft et al., 
2006 
BA24 seqA-yfp mutS- dam- Radman Lab, 
Babic et al., 
2008 
XL-1 Blue endA1 supE44 thi-1 recA1 gyrA96 hsdR17 
relA1 lac[F¢ proAB lacqZ∆M15 Tn10(Tetr)] 
Stratagene 
BL21 DE3 F- ompT hsdSB (r-Bm-B) gal dcm met (DE3) Novagen 
DH5α endA1 lacZΔM15 recA1 F- Invitrogen 
GM124 F-, lacZ118(Oc), rpsL275(strR), dam-4 CGSC 
HFR3000 Hfr(PO1), supQ80?, λ, e14, relA1, spoT1, thiE1 CGSC 
KL19 Hfr(PO67) CGSC 
 
 
























mVenus FWD 5' CGC GGA TCC A GGA AGC AAG  GGC GAG GAG 
CTG 3' 
REV 5' CGT GGA TCC CCG TAC AGC TCG TCC ATG CCG 3' 
mDHFR FWD 5' GCA GTA GGA TCC A GGA GTT CGA CCA TTG AAC 
TGC 3' 
REV 5' GCA GTA GGA TCC GTC TTT CTT CTC GTA GAC 3' 
309-858 TraI 
Fragment 
FWD 5' GCA GCA CAT ATG GCT TCA CAG GAC GGG C 3' 
REV 5' GCA GCA CTC GAG TAA GGA CTT CTG ATG ACT 
GAT AGC CG 3' 
I161A FWD 5' CAA GCA GAA GAA CGG CGC CAA GGC CAA CTT 
CAA G 3' 
REV 5' CTT GAA GTT GGC CTT GGC GCC GTT CTT CTG CTT 
G 3' 
G67A FWD 5' ACC CTG GGC TAC GCC CTG CAG TGC TGC TT 3' 
REV 5' AAG CAC TGC AGG GCG TAG CCC AGG GT 3' 
I47A FWD 5' CCC TGA AGC TGG CCT GCA CCA CCG G 3' 
REV 5' CCG GTG GTG CAG GCC AGC TTC AGG G 3' 
K998A FWD 5' TGC CGG TGT GGG TGC GAC CAC ACA GTT T 3' 
REV 5' AAC TGT GTG GTC GCA CCC ACA CCG GCA 3' 
A593V FWD 5' GCC AGC GTG AAA GTC GGA GAA GAG AGC 3' 
REV 5' GCT CTC TTC TCC GAC TTT CAC GCT GGC 3' 
S739N FWD 5' CGC CTG CAG GTG GCA AAC GTC AGT GAA GAT 
GC 3' 
REV 5' GCA TCT TCA CTG ACG TTT GCC ACC TGC AGG CG 
3' 
D672N FWD 5' GAC CGC TAT GTT ATC AAC CGG GTG ACG GCG 3' 
REV 5' CGC CGT CAC CCG GTT GAT AAC ATA GCG GTC 3' 
 
Table 2.4 All primers used in this study for cloning. Primers were used for cloning 
PCR products from plasmids and for Quikchange mutagenesis.  
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CHAPTER 3 
FLUORESCENCE MICROSCOPY USING SEQA-YFP TO TRACK 
TRANSFER OF F PLASMID 
 
 
Objectives of this Chapter 
 A plate based mating assay is a measure of the end product of a mating event. 
We want to be able to track mating as it occurs, and be able to assay the process of F 
plasmid transfer as it happens. There are steps of the mating process that we may be 
missing with plate-based assays. Vital information about the process such as changes 
in DNA transfer, plasmid establishment, and plasmid integration may be overlooked. 
Using the live cell SeqA-YFP assay, we will be able to track DNA transfer, and 
possibly detect differences in the DNA transfer process, plasmid establishment, and 
other steps in the mating process. We may also be able to determine properties of TraI 
that were previously unknown and could not determine using a plate based assay, 
such as if helicase activity is required for DNA transfer or plasmid establishment. We 
know bacterial mating can occur rapidly, but the system can observe DNA transfer in 
near real time (Babic et al., 2008).  
 
Results 
Using Hfr Strains to Test the System 
The first set of experiments with Hfr strains was undertaken to ensure the 
SeqA-YFP system would work in our hands. Microscopy mating assays with various 
Hfr strains were conducted to ensure the system was operational. The recipient strain, 
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BA24, graciously provided by the Radman Lab, contains the SeqA-YFP fusion 
protein. This fusion protein is on the native bacterial chromosome, under control of 
the native promoter. It is expressed as native SeqA would be expressed in the 
cell.  This strain is dam-, as it needs to lack Dam methylase to create a fluorescent 
focus upon transfer of single-stranded methylated plasmid DNA. When a single 
strand of methylated DNA is transferred to the dam- recipient, second strand synthesis 
creates a hemimethylated plasmid that SeqA-YFP will bind to and create an aggregate.  
One of the donor strains used in Babic et al., 2008, was Hfr3000, and it was 
the first strain that we tested with BA24 to see if the system would work (Figure 3.1).  
Focus formation is measured by the reduction of background fluorescence in a 
recipient cell and the visualization of a punctate, circular structure (the focus) within 
the cell. Foci formation was confirmed to be consistent with results from Babic et al., 
2008. A dam- donor strain strain, GM695, was used as a negative control to confirm 
that foci formation will not occur when both donor and recipient are dam-. We did not 
see foci formation with both a dam- donor and recipient (Figure 3.2). As a positive 
control, we used the strain GM1655 dam+. This strain contains the SeqA-YFP fusion 
protein, and has its native Dam methylase. It forms foci without mating, indicating 
SeqA-YFP functions in its native role without disruption due to the fusion of YFP. 
We also mated BA24 with other Hfr strains with the oriC present at different 
locations within the genome to determine if oriC location was important to transfer 
timing. We determined location of the oriC did not change how quickly SeqA-YFP 
reported the DNA transfer event (Figure 3.3). 
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Figure 3.1. Microscopy mating assay with the recipient BA24 and donor Hfr3000. 
Cells are imaged at 3, 30, and 60 minutes after mixing and plating on an agarose slab. 
The development of a focus over time within the recipient cell can be seen. Top row, 





60	  min 30 min 
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Figure 3.2. The dam- donor GM695 did not cause foci formation since the transferred 












	   65	  
	  
Figure 3.3. An additional Hfr strain, KL19, was used to show different Hfr strains 
with the oriC positioned at different minutes in the genome still showed foci 
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The SeqA-YFP System Can Be Used To Track F Plasmid Transfer 
Once the Hfr strains had been used to test and confirm the system was 
operational, we next tested F plasmid containing donor strains. We had analyzed the 
F plasmid sequence in Genbank to determine if using the system with F was possible 
since it does not contain an oriC, but since F plasmid does not contain an array of 
GATCs similar to the oriC it was unknown if the system would function. The first F 
plasmid strain tested was XK1502 F∆TraI p99i (Figure 3.4). XK1502 F∆TraI is host 
to an F plasmid that has a TraI deletion and carries tetracycline resistance in its place, 
creating a transferrable selectable marker for traditional plate based assays. The p99i 
plasmid is pTrc99a with traI cloned into it. With the XK1502 F∆TraI p99i strain, we 
determined that it is possible to track focus formation using F plasmid strains. We 
saw foci formation in this F plasmid strain, and confirmed the system works to track 
F plasmid (Figure 3.4).  
Once we had determined the assay was possible with F plasmid strains, we 
next set out to test the TraI i31 mutants with the system. Upon running the assay with 
p99i TraI i681, we noted that the time it took for a focus to form in this strain (44.5 ± 
14.5 minutes) was less than the time required for p99i TraI WT (125.4 ± 32.4 
minutes). Intrigued by this difference, we determined that the average time to focus 
formation in p99i TraI i681 was significantly shorter than in the WT strain (Figure 
3.5). We continued testing the rest of the i31 mutants in our collection, i369, i593, 
and i1753. The time to focus formation for all the i31 mutants tested was shorter than 
that of WT (Figure 3.5). The average time for a focus to form in i681 in this assay is 
44.5 ± 14.5 minutes (n = 3), whereas the average time in WT is 125.4 ± 32.4 minutes 
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(n = 3). The time it took for a focus to form with the strain containing WT TraI was 
much longer than the time it took for the i31 mutant. These data correlate with the 
mating assay data collected in Haft et al., 2006. That mating assay data shows 
increased mating efficiencies over WT for the i31 mutants tested in the microscopy 
mating assay. The average foci formation times for i369, i593, and i1753 are 67.0 ± 
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Figure 3.4. Microscopy mating assay with the recipient BA24 and donors (A) 
XK1502 p99i WT TraI and (B) XK1502 i681 TraI. Cells are imaged at 3, 30, and 60 
minutes after mixing and plating on an agarose slab. The development of a focus over 
time within the recipient cell can be seen. For A and B, Top row, bright field, middle 
row fluorescence image, bottom row, fluorescence overlay. 
A 
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Figure 3.5. TraI variants with an i31 transposon insertion at various points in the 
protein sequence have altered rates of transfer compared to wild type as visualized by 
the fluorescence microscopy assay. For each cell line, data from at least three 
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TraI Variant Average Focus Formation Time (min) 
i369 67.0 ± 19.7 
i593 45.7 ± 22.4 
i681 44.5 ± 14.5 
i1753 57.5 ± 23.7 
WT 125.4 ± 32.4 
 
Table 3.1. The average foci formation times for all the i31 mutants and WT. Values 
for each variant represent the combination of at least three independent experiments. 
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Interrupted Mating Assay Shows No Change in Second Strand Synthesis 
We next wanted to test if the differences seen in the live cell mating assay 
were caused by changes once the DNA had entered the recipient cell. It is possible 
that the rate of second strand synthesis is changed in the i31 mutants. The assay was 
modified to identify foci that had formed within a defined period of mating prior to 
imaging. If a change in second strand synthesis had occurred, similar numbers of foci 
would be present at different time points. The cells were mated for a set amount of 
time (either 5, 10, or 15 minutes), and subsequently interrupted by vigorous shaking 
and addition of 0.01% SDS. The interrupted cells were then imaged for 60 minutes 
and foci were counted. The percent of cells that contain a focus in the i31 strains is 
markedly different versus WT (Figure 3.6). At the 15 minute mating time point, WT 
has 0.39% of cells with a focus, while the i31 strains have 0.72% and above. The i369 
strain has 0.79%, i593 has 1.39%, i681 has 1.4%, and i1753 has 0.72% of cells with a 
focus at the 15 minute time point. These numbers seem small, but the average mating 
efficiency in the i31 strains is 10-1 to 10-2, meaning there is on average 1 mating event 
for every 100 to 1000 recipient cells (which is 0.01-0.1 %). These data do not indicate 
a change in second strand synthesis since the percentage of cells with foci are 
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Figure 3.6. Results of the interrupted mating assay, the percentage of cells with a 
focus over time for TraI i31 mutants. Values (expressed as a percentage of all cells) 
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Determining if TraI Helicase Activity is Required for DNA Transfer 
To test if mating was possible without helicase activity, we testing mating 
efficiency using a TraI K998A mutation. This mutation disrupts the helicase domain, 
and it does not form colonies in a traditional mating assay. It has no mating activity in 
the plate based assay, and we wanted to determine if any DNA was transferred and if 
the defect in mating was in plasmid establishment or DNA transfer. The SeqA-YFP 
system visualizes DNA transfer and allows us to track the entire process, not just the 
end result. The system can allow us to distinguish between DNA transfer and plasmid 
establishment. No foci formed in the recipient when using this strain as a donor. Cells 
were tracked for over three hours, well past the window when foci would normally 
appear. This indicates that TraI will not transfer DNA without helicase activity. 
 
Using a Low Mating Efficiency Strain TraI i593 YFP 
To determine if foci formation in a strain with a mating efficiency close to or 
lower than WT in a plate based assay has similar results in the microscopy assay, we 
ran TraI i593-YFP in the microscopy mating assay. WT TraI has a low mating 
efficiency, around 10-3 to 10 -4, which is similar to i593-YFP. We wanted to use the 
i593-YFP strain as a comparison for WT, to determine if the measured foci formation 
time in a strain with a mating efficiency close to or lower than WT TraI has foci 
formation times similar to or lower than WT. Although TraI i593-YFP is also 
fluorescent, we did not anticipate this signal would interfere with data collection since 
the fluorescence signal for foci is incredibly high. TraI i593-YFP was run with the 
normal microscopy mating assay recipient BA24 and we encountered some 
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unexpected results. This was meant as a control for the microscopy mating assay data 
set and did not anticipate the mating events would be difficult to image, even with 
two fluorescent signals. We did see what we thought were foci initially, but they are 
not actually foci (Figure 3.7). Foci that appear after a mating event are almost 
completely circular in appearance. The structures that appeared were not circular and 
had somewhat irregular shapes, and there were more than one in a single cell, which 
does not occur with foci formed after mating events. The shape of the structures also 
changed over time, which does not occur with mating event foci. These aggregate 
structures are not foci formed in the recipient, rather they are structures formed in the 
donor cells. The donor cells have a higher fluorescence signal than the recipient cells, 
and thus we were able to distinguish between donor and recipient. The mistaken 
identity occurred due to both donor and recipient possessing YFP signals. These 
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Figure 3.7. When mated, XK1502 TraI i593-YFP (top image) forms aggregates as 
seen in the red circle that appear similar to a focus formed by DNA transfer. However, 
the shape is not perfectly circular, as in an example Hfr3000 (bottom image). Foci 
formed by mating in BA24 are circular and punctate, while the i593-YFP aggregates 
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 After determining the structures seen are not foci, the donor cell line was 
analyzed on the microscope by itself, with no mating (no BA24). The aggregate 
structures form without a recipient strain present. To determine if the structures we 
are seeing are aggregates due to the insertion of YFP into TraI or if the aggregation is 
due to TraI interacting with F plasmid, p99i TraI i593-YFP was transformed into 
XK1502 F-. Without F, there is no F plasmid or oriT for TraI to aggregate onto. We 
also imaged i593-YFP I161A to determine if altering the folding stability of YFP 
alters the formation of the aggregate. After imaging each cell line separately, we 
found that the aggregate forms with F plasmid present (forms for both i593-YFP and 
i593-YFP I161A) but does not form in an F- cell line. The i593-YFP cell line is not 
useful for creating a foci formation comparison for WT and instead we discovered 




Using the SeqA-YFP System With Hfr Strains  
Upon receiving the strains from the Radman Lab, we needed to ensure the 
assay would work for us, and would work as described in Babic et al., 2008. We 
chose to use the same donor strain as they did, Hfr3000. Further controls with GM695 
and other Hfr strains were run to confirm the experimental system worked as 
published. Despite somewhat different conditions, the system was operational and 
could be used for further experimentation. These results meant we could go ahead 
with using the system with F plasmid and potentially tracking F plasmid transfer.  
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Changes in DNA Transfer are Present in the TraI i31 Mutants 
Once we knew the system worked, we tested the system with the F plasmid 
strain XK1502 F∆TraI p99i TraI.  We were able to observe F plasmid transfer, which 
was surprising since F plasmid does not contain an oriC (Figure 3.4). After 
determining the average foci formation time for the WT strain, we decided to use a 
TraI mutant strain in the assay, XK1502 p99i i681. This strain has a known higher 
mating efficiency in the same strain background. Testing this strain in the assay, we 
discovered a difference in foci formation time. The time took to form foci in this 
strain was markedly reduced from WT TraI.  
We decided to run the rest of the i31 strains that we had in the assay, i369, 
i593, and i1753, and found these were also different from WT. All of these mutants 
have a known higher mating efficiency than WT TraI. In conjunction with the mating 
assay data, this indicated a change in the mating machinery previously unidentified. 
We saw DNA appear in the recipient at earlier times in the TraI mutants than in WT. 
The change in DNA transfer indicated a change in the mating process, which 
appeared to occur more quickly in the i31 mutants. This result was unexpected, 
although the data correlate with the published mating efficiency data for these strains 
in Haft et al., 2006.  We did not anticipate being able to so markedly see a difference 
in the time it took to form foci. All of the i31 mutants have a faster foci formation 
time than WT, but there are differences in the average time to foci formation between 
the i31 mutants. The i593 and i681 mutants have the shortest average time to foci 
formation, while the i369 and i1753 mutants take longer to form foci than i593 and 
i681, although still faster than WT TraI.  
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These data show there are possibly different effects that the i31 has at 
different sites. The i31 mutations are in different domains of the protein, and the ones 
that are in the same domain are on different secondary structure elements of that 
domain. The i369 site is in a predicted unstructured region of TraI, while i593 and 
i681 are in the TSA region of TraI. The i593 mutation is at the end of an α-helix, 
while the i681 mutation is in a β-sheet, and the i1753 mutation is at the C-terminus of 
the protein. The differences in where the i31 is situated and the structural elements it 
is disrupting could be causing the apparent differences in foci formation time.  
Mating in cells proceeds on a rapid time scale and only takes minutes at most 
to complete. Plate based mating assays usually mate cells for 20 to 60 minutes to 
capture as much mating activity as possible, but could be run for as little as five 
minutes and still give a good measure of mating efficiency. In the microscopy mating 
assay however, few mating events occur for 10-20 minutes after the cells are mixed 
due to the set up of the experiment. Most mating activity is captured after that initial 
period, and the microscopy mating assay proved to be able to measure foci formation 
in short time frame, although some foci did form before we could begin tracking 
mating pairs.  
Due to foci forming before the mating pairs were being tracked and to 
determine the change in the mating process, the first step was to modify the mating 
assay to measure foci formation during set mating times. This would determine if the 
change in the mating efficiency and DNA transfer time was due to a change in the 
donor or recipient. To determine if the change was due to changes in second strand 
synthesis in the recipient, the interrupted mating assay was developed (described in 
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the methods section). This assay would allow us to determine the percentage of cells 
that contain a focus after mating for a set amount of time.  
After running the interrupted mating assay, we did not find any indications 
that there was a defect in second strand synthesis (Figure 3.6). The percentage of cells 
that contain a focus in the i31 strains over time versus wild type is different. We did 
not observe any changes that indicate a change in the recipient is responsible for the 
observed change in DNA transfer.  
 
The K998A TraI Mutant Shows No DNA Transfer  
It was possible the DNA was being transferred, but not established in the 
recipient cell due to the ATPase defect in the K998A mutant. Our microscopy data 
indicate this is not the case, and in fact no DNA is transferred in an ATPase TraI 
mutant. TraI requires a functional ATPase to transfer DNA, as seen in our data. We 
also wanted to know if we could visualize foci formation in a TraI strain with a 
mating efficiency much lower than WT. We know that we do not see mating in an 
ATPase mutant, but we do see mating at a much lower efficiency in the TraI-YFP 
fusion proteins that have been created for other assays. These strains have a mating 
efficiency in the range of 10-4 to 10-5, which is lower than WT TraI, and much lower 
than the i31 strains. The TraI-YFP fusion proteins were originally constructed for use 
in microscopy, but were not used for that purpose since the protein is expressed from 
a plasmid and expressed in a high copy number. This creates a high background 
signal and transfer of a single TraI-YFP from donor to recipient could not be 
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visualized. However, with the SeqA-YFP recipient line, we would not need that 
function of the donor line.  
 
The i593-YFP Cell Line Was Not a Good Control 
Using the i593 TraI-YFP fusion protein, we mated them with BA24 (SeqA-
YFP) and tracked mating cell clusters (Figure 3.7). Determining mating cell clusters 
was difficult since both donor and recipient are fluorescent at the same wavelength. 
However, one cell line has higher signal intensity than the other, thus mating cell 
clusters could be determined. Once clusters were identified, they were tracked over 
time. We did not observe any foci formation, instead we observed aggregate like 
structures in the donor cells (Figure 3.7). These structures are not circular foci like 
those formed in recipient cells in other mating assays on the microscope, these 
structures were more irregularly shaped and the observed structure would vary. The 
occurrence of these structures was in approximately 5-10% of the observed cells. We 
hypothesized these structures were TraI-YFP aggregating on F plasmid.  
To determine if these structures were TraI-YFP aggregating to F plasmid, we 
transformed the plasmid into an F- strain. We imaged the cells alone without recipient 
in the F- strain, and we also imaged i593-YFP and i593-YFP I161A with no recipient. 
We determined the cells do not form these structures without F plasmid present, 
meaning the cells are likely aggregating on F plasmid (Figure 3.7). The structures are 
present in the cells without mating, (i593-YFP alone) confirming that the structures 
are in the donor cell and not caused by DNA transfer to the recipient. Destabilizing 
TraI-YFP (the I161A mutant) does not cause the structures to disappear.  
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These data are interesting in that they show structures forming in the donor 
cells that were previously not seen. However, the purpose of using this cell line was 
to determine foci formation time for a strain with a mating efficiency lower than WT, 
and in this regard these data do not give any useful information. It is also possible the 
cells with the aggregate structure were not healthy cells and producing these 
structures as a result of being sick or dying. A method of staining for dead and dying 
cells could be used to determine if the cells with aggregates were indeed dead. 
However, these aggregates are not observed when F plasmid is not present, so they 
are more likely due to an interaction between TraI-YFP and F plasmid.  
 
Overall Conclusions of the Chapter 
Our data indicated a change in the mating process in the donor, and not in 
second strand synthesis. Since we did not see a change in second strand synthesis, we 
wanted to know what else could possibly be the cause of the change in DNA transfer 
seen in the i31 mutants. We proposed the model of altered protein stability of the TraI 
i31 mutants could be the cause behind these data. We also wanted to know if ATPase 
activity was required for DNA transfer. We used an ATPase mutant, TraI K998A to 
test if knocking out ATPase activity knocks out DNA transfer. We knew knocking 
out the ATPase activity of TraI knocks out mating in a plate-based assay. It was not 
known if the mating defect was due to lack of DNA transfer or lack of plasmid 
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CHAPTER 4 
INVESTIGATING THE STABILITY OF TRAI 
 
Objectives of the Chapter 
The work presented herein investigates possible explanations for the altered 
DNA transfer rate observed in the microscopy work on the TraI i31 mutants. One of 
the possible explanations of the higher efficiency in DNA transfer could result from 
increased instability of the i31 TraI mutants. This line of investigation was probed 
through multiple methods. We utilized protein fusion constructs and direct 
measurements of protein stability to analyze if altered stability of the TraI mutants 
could be part of the cause behind the change in the i31’s mating efficiency. As 
reviewed in the introduction, TraI will tolerate the insertion of small proteins and cell 
lines with TraI fusion proteins can transfer DNA.  
One of the crucial functions of TraI in bacterial conjugation is the nicking of 
the plasmid during the mating process. TraI is highly specific for the nic site, and will 
not nick effectively if the sequence is not specific for F plasmid TraI (Stern and 
Schildbach, 2001. It may be possible the nic activity of the i31 mutants has been 
altered and be part of the cause of the altered DNA transfer and increase in mating 
efficiency. We examined the nicking activity of TraI, to determine if the activity was 
altered in the i31 mutants.  
We also investigated an alternative model, examining if altering the TSA of 
TraI could partially explain the changes in mating efficiency. The recent structure of 
the TSA, solved in Redzej et al., 2013, indicated that the TSA of R1 TraI is located 
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within an independent folding unit and a structural domain. The TSA of R1 TraI and 
F TraI are almost entirely identical, with two amino acid changes between the two 
domains in the solved structure. In their study, various residues within the TSA were 
mutated, altering protein translocation frequency (Redzej et al., 2013). Previous work 
had also identified that insertion of 31 amino acids (i31) in the TSA without the 
presence of the TSB eliminated protein transfer (Lang et al., 2010, Haft et al., 2006). 
Their work indicated only one TS was required for transfer (Lang et al., 2010).  
 
Cloning DHFR into TraI Did Not Cause Changes in Mating Efficiency 
Two constructs were successfully engineered, TraI i369-DHFR and TraI i681-
DHFR. The clones were confirmed by sequencing and expression test to confirm 
expression of full-length protein and absence of truncation products. Using these two 
clones, we proceeded to test the effects of MTX on TraI-DHFR. MTX acts to 
stabilize DHFR and acts to inhibit the unfolding of DHFR (Ainavarapu et al., 2005). 
Mating assays using control strains in the presence of varying concentrations of MTX 
were run to determine the upper limit of toxicity that could be tolerated in a mating 
assay. It was determined that cells with WT TraI could tolerate 50 µM of MTX 
without any significant change to mating efficiency caused by the introduction of the 
drug to the mating assay. Higher concentrations caused cytotoxicity and reduced 
mating efficiency in control strains (WT and i31s without DHFR inserted).  
Since concentrations of MTX over 50 µM caused cytotoxicity, the mating 
assay protocol was also optimized for length of use of the drug during mating. Cells 
were mixed with MTX for varying amounts of time prior to mating to determine if 
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drug exposure time would affect mating efficiency. We determined 15 minutes of 
exposure combined with 60 minutes of mating would not alter the mating efficiency 
due to drug exposure. This is the length of mating assays without drug, keeping both 
types of mating assays standard to each other. Both i369-DHFR and i681-DHFR were 
mated with the recipient strain GM124. Addition of DHFR to TraI did not change the 
mating efficiency of the construct (figure 4.1). The results of the mating assays 
indicated no change in mating efficiency of the TraI-DHFR constructs when MTX 
was added to the mating assay (Figure 4.1).  Since there was no statistically 
significant change in mating efficiency with or without MTX (Table 4.1), we decided 
to shift to another approach to determine if altering protein stability could cause 
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Figure 4.1. The mating efficiency of TraI-DHFR mutants with and without 50 µM 
methotrexate (MTX). No statistically significant difference in mating efficiency with 
or without drug was measured. For each cell line, data from at least three independent 
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2.17 • 10-3 
± 1.34 • 10-3 
0.11 ± 0.034  0.078 ± 0.013 0.058 ± 0.039 
50 µM 
MTX 
1.3 • 10-3 ± 
7.16 • 10-4 
0.056 ± 0.019 0.025 ± 0.01 0.03 ± 7.6 • 10-3 
 
Table 4.1. Mating efficiency of TraI-DHFR with and without MTX. Values are 
reported as the average of at least three independent experiments with standard 
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TraI-DHFR Discussion 
The addition of MTX to mating assays with DHFR inserted into TraI did not 
create any noticeable changes in the mating efficiency of those strains. Even after 
protocol optimization, we did not see any changes in mating efficiency. Insertion of a 
22 kDa protein into TraI did not alter mating efficiency, and previous evidence 
suggested mating efficiency was lowered when a protein was inserted into TraI. In 
other systems that use DHFR to probe protein transfer across membranes, transport 
without MTX is not affected; only when drug is added to the system is there a change 
in protein transport (Eilers and Schatz, 1986). 
We decided to shift the approach and look for alternative strategies for 
probing protein stability, as the TraI-DHFR work did not show any change in mating 
efficiency upon addition of MTX. We wanted to investigate if a similar approach 
could be undertaken with a different protein. YFP is a stable protein, and we wanted 
to examine if adding YFP to TraI and altering the stability of YFP by base 
substitutions could produce changes to the mating efficiency of these constructs.  
 
Mutating YFP Inserted into TraI Causes a Change in Mating Efficiency 
We identified point mutations that would most likely cause a change in the 
stability of the protein. The first mutation selected was G67A, a chromophore 
mutation that destabilizes the chromophore and causes the protein to be able to 
reversibly fold (Kutrowska et al., 2007). The second mutation selected was I161A, a 
mutation that destabilizes a hydrophobic region of the protein, indicated in that role 
by Melnik et al., 2011. These two mutations, along with a control, I47A, were created 
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in both i593 and i681 YFP. Creating these mutations at two different sites was critical 
to understanding if altering the stability in one site created a different mating 
phenotype than the other site of TraI.  
The resulting strains were mated in plate based mating assays with the 
recipient strain GM124. The resulting mating efficiencies are shown in Table 4.2. In 
both sites, the point mutants G67A and I161A altered the stability of the protein and 
mating efficiency recovered relative to TraI-YFP (Figures 4.2 and 4.3). The mating 
efficiency of TraI-YFP prior to mutation was on the order of 10-5 to 10-4. With both 
mutations, the mating efficiency recovered into the range of 10-3 to 10-2. These are 
statistically significant rises, indicating that significantly reducing the stability of YFP 
improved the mating efficiency. The mating efficiency of I47A did not change 
relative to TraI-YFP, indicating changing a random single residue (isoleucine in 
particular) alone will not alter mating efficiency. There was no previously published 
evidence to specify the residue was involved in altering stability. The residue is 
solvent exposed and at the end of a β-sheet, similar to I161, but does not alter mating 
efficiency when mutated. The point mutation needs to be targeted to altering the 
stability of the protein to produce an effect on mating. The mating efficiency changes 
seen at the i681 site are the same changes seen at the i593 site. This indicates that the 
changes wrought by the i31 insertion are not due to where the i31 is in the protein, 
and due rather to altering the stability of the protein.  





Figure 4.2. Mating assay data for i593-YFP point mutants. Mating efficiencies 
(transconjugates per donor cell) of the YFP point mutants in the i593 site were 
compared to WT TraI from plasmid p99i. Values for each cell line represent the 
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Figure 4.3. Mating assay data for i681-YFP point mutants. Mating 
efficiencies (transconjugates per donor cell) of the YFP point mutants in the i681 site 
were compared to WT TraI from plasmid p99i. Values for each cell line represent the 
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Strain Mating Efficiency 
p99i WT 4.0 • 10-4 ± 3.2 • 10-4 
i593 0.12 ± 0.066 
i593-YFP 5.4 • 10-5 ± 5.1 •10-5 
i593-YFP G67A 1.3 • 10-3 ± 1.1 • 10-3 
i593-YFP I161A 9.3 • 10-4 ± 2.7 • 10-4 
I593-YFP I47A 1.72 • 10-5 ± 4.51 • 10-6 
i681 0.11 ± 0.047 
i681-YFP 1.1 • 10-4 ± 7.45 • 10-5 
i681-YFP G67A 7.3 • 10-3 ± 5.34 • 10-3 
i681-YFP I161A 3.1 • 10-3 ± 2.9 • 10-3 
i681-YFP I47A 8.37 • 10-5 ± 5.12 • 10-6 
 
 
Table 4.2. Mating efficiency (transconjugates per donor) of the TraI-YFP point 
mutants. Values are reported as the average of at least three independent experiments 
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TraI-YFP Discussion 
In this work, we focused on probing the stability of TraI via an inserted 
protein. Although the TraI-DHFR work did not demonstrate a change in mating when 
MTX was added, we were able to prove that altering stability of the inserted protein 
can alter the mating efficiency of the strain with TraI-YFP. This is significant, as this 
indicates that altering stability may be part of the cause of the altered phenotype of 
the i31 mutants. The data at both i593 and i681 showed the same pattern of mating 
efficiency recovery with the G67A and I161A mutations. Altering the stability of 
YFP did indeed cause a recovery in mating efficiency. However, this is changing the 
stability of an inserted protein, not of TraI itself. While an important tool, inserting 
proteins into TraI and altering them is not the same as altering TraI itself. This data 
indicates a possible cause for the i31 phenotype, but does not fully explain it. Using 
this data as a support for the model of altered stability causing the i31 phenotype, the 
next logical step was to measure the stability of the TraI i31 mutants directly. 
Determining stability of the protein without an inserted protein could possibly 
provide more insight into the cause of the mating assay and DNA transfer rate 
differences in the i31 mutants.  
 
TraI Mutant Nicking Activity is Not Changed  
To determine if the nicking activity of the TraI i31 mutants was altered, we 
performed a nicking activity assay on full-length WT TraI and i31 mutants (see 
Methods).  No changes in nicking activity of the i31 mutants versus wild type were 
observed (Figure 4.4). Analysis of the gels to determine the percent of oligo cut 
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showed that the proteins all have nicking activity (Figures 4.5 and 4.6). However 
there was wide variability seen in the percentages between different gels. These data 
also indicate that the mutants are active in vitro, and nicking activity is not adversely 
affected by the mutation. These data lead us to the conclusion that nicking activity is 
not affected by the i31 mutation and not part of the reason behind the changes seen in 
the i31 mutants. 
 
Interactions of TraI and TraD in the Nicking Assay 
The nicking assay was originally intended not only to show the i31 mutants 
have in vitro activity, but also to also quantitate the nicking reaction and determine if 
the nicking activity of the i31 mutants was significantly higher than that of WT. We 
did not see any major changes in nicking activity (Figure 4.4). We decided to 
investigate if adding TraD to TraI in the nicking reaction would enhance nicking 
more in the i31 mutants versus WT. When TraD is added to TraI, it nicks supercoiled 
oriT DNA and converts it to open circular plasmid more than without (Lang et al., 
2011). Since we know in this assay TraD stimulates the activity of TraI, we wanted to 
know if this would be the case in the nicking assay, where we use short fluorescently 
tagged oligo to measure nicking activity. We used TraD C-terminal domain (CTD) as 
full length TraD contains a membrane insertion domain and cannot be purified with 








Figure 4.4. Results of a time course nicking assay with WT TraI and the i31 mutants. 
Reactions were run for either 5 or 60 minutes, and halted with addition of Proteinase 
K. Upper band (uncut Cy5 oligo) and lower band (nicked Cy5 oligo) show no major 
differences between the constructs at the 5-minute or 60-minute time point. No 
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Figure 4.5. Analysis of the percentage of oligo cut of total oligo in the lane from a 
time course nicking assay with WT TraI and the i31 mutants. Reactions were run for 
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Figure 4.6. Analysis of the percentage of oligo cut of total oligo in the lane from a 
time course nicking assay with WT TraI and the i31 mutants. Reactions were run for 



































































































	   97	  
 
Addition of TraD Does Not Cause Changes in Nicking Activity 
TraD C-terminal domain (CTD, ∆N130) from F plasmid was added to the 
nicking reaction (see materials and methods) with TraI at varying concentrations to 
determine if TraD could enhance the nicking reaction. We saw no apparent increase 
in nicking activity with the addition of TraD to TraI; analyzing the intensity of the 
bands from the nicking reaction did not show any significant increase in nicking 
activity when TraD was added (Figure 4.7).  
 
Nicking Assay Discussion 
The nicking assay was able to show that all the constructs do have nicking 
activity, and they are all active at approximately the same levels. There were no large 
changes in activity seen (Figures 4.5 and 4.6). The assay also proved to be highly 
variable from gel to gel, and the results only served to underscore the variability in 
the assay. The assay is not a good measure of the quantitative nicking activity of the 
constructs, as can be seen in the differences in activity between Figures 4.5 and 4. 6. 
Unlike the published results from Lang et al., 2011, we did not see any enhancement 
in the nicking activity of TraI when TraD was added to the reaction. This could be 
due to differences in the type of assay, as we were using small oligos and Lang et al. 
were using supercoiled oriT DNA. We were also using a partial construct of TraD 
that is not full length, and that could have affected the reaction. To fully assess the 
effects of TraD on TraI, we would need to run the same assay as in Lang et al., but as 
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Figure 4.7. Addition of TraD∆N130 to wild type TraI, i593, or i681 in the nicking 
assay at various concentrations did not change the nicking activity of TraI. TraI and 
TraD∆N130 were incubated in the nicking reaction for 60 minutes, and the reaction 
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Differences in the Stability of TraI 309-858 Fragments  
The changes in mating efficiency seen when TraI-YFP was mutated indicated 
that altering the stability of TraI is part of the reason for the change in DNA transfer 
rate in the i31 mutants. In the original paper reporting the i31 mutants, the authors 
speculated the increase in mating efficiency seen in certain i31 mutants was due to a 
release from a form of negative regulation (Haft et al., 2006). Previous work in the 
lab by a former post doc, Lubos Dostal, analyzed some of the i31 mutants and found 
that the mutants had reduced affinity for ssDNA in their helicase associated binding 
sites (Dostal and Schildbach, 2010). They also had a reduction in the apparent 
negative cooperativity of binding. These results, along with other data, indicated the 
negative cooperativity between the ssDNA-binding domain and the relaxase domain 
(both of which bind ssDNA) is a major regulatory step in F plasmid transfer (Dostal 
and Schildbach, 2010). The changes in ssDNA binding partially explain but do not 
fully explain why there is a change in mating efficiency.  
While changes in ssDNA binding may be part of the reason behind the altered 
phenotype, changes in the protein’s stability may be behind the changes in ssDNA 
binding. Alternatively, changes in ssDNA binding and changes in stability may be 
working as additive effects to increase mating efficiency. To more directly address 
the question of the stability of TraI, we conducted stability measurements of TraI. We 
proposed a model whereby the i31 caused a measurable change in the stability of the 
protein, which could possibly alter the accessibility of the protein to the pore. The 
protein more than likely at least partially unfolds as it transits the pore (see TraI-YFP 
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data) and the stability of the protein may cause a change in mating efficiency and 
explain the altered DNA transfer seen in the microscopy data. 
The transposon insertion inserts 31 amino acids with no obvious structure. 
Inserting an unstructured peptide into the backbone of TraI could result in changes to 
the stability of the local environment, or the global environment of the protein. To 
determine if there is a global change in the stability of the protein, we employed 
chemical titration measured by circular dichroism to probe the stability of the protein. 
We used a fragment of TraI in the study of the stability of the protein, as full length 
TraI could prove problematic in these types of experiments. Full length TraI has 
intrinsically disordered regions that would not lend themselves well to protein 
unfolding studies. A previous post doc, Lubos Dostal, had conducted trypsin digests 
on TraI, and identified the region of 309-858 as a trypsin stable fragment (Dostal and 
Schildbach, 2010). This region encompasses the i369, i593, and i681 insertion sites. 
This fragment with the different i31 insertion sites was then cloned into the pET24a 
vector, and expressed in BL21 cells (see materials and methods). 
Wavelength scans of the fragments for wild type, i369, i593, and i681 were 
carried out. The signal for each construct indicated primarily α-helix secondary 
structure in each sample, but i593 showed a difference in its wavelength scan 
compared to the other constructs (Figure 4.8). There is a shift in the minimum of the 
scan for i593 compared to the minimum at 210 nm for the other constructs, indicating 
more random coils present in the sample. This could be due to partial unfolding of the 
protein, or a change in the structure of the protein due to the i31 insertion. After the 
wavelength scans, titration curves were collected for all constructs (Figures 4.9, 4.10, 
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4.11, 4.12, 4.13). The ∆GH20 of unfolding values are reported in Table 4.3. There was 
no statistically significant difference between the ∆G values.  
The m value represents the dependence of the free energy of unfolding (the 
∆G value) on denaturant concentration. The m value of a protein correlates with the 
amount of protein that is surface exposed to solvent as it unfolds (Myers, Pace, and 
Scholtz, 1995). The calculated m values were much smaller than what is reported in 
the literature for proteins of similar size (Myers, Pace, and Scholtz, 1995). As well as 
small m values, the unfolding curve for i593 has an altered baseline compared with 
the rest of the constructs (Figure 4.14). This may be due to increased contaminants in 
the sample, or due to the presence of more random coils in the protein structure. The 
i593 construct, as detailed in the methods, required an additional column during 
purification. Even after the additional column, the construct could rapidly degrade 
from full-length fragment to a degradation product and the sample had to be carefully 
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Figure 4.8. Circular dichroism wavelength scans of the 309-858 fragments at 10 µM 
protein concentration. A shift in the spectrum of i593 can be seen compared to the 
rest of the fragments. Fragments were scanned at a concentration of 10 µM in buffer 
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Figure 4.9. Unfolding titration curve for WT TraI 309-858. Plot shown is the average 
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Figure 4.10. Unfolding titration curve for i369 TraI 309-858. Plot shown is the 
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Figure 4.11. Unfolding titration curve for i593 TraI 309-858. Plot shown is the 
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Figure 4.12. Unfolding titration curve for i681 TraI 309-858. Plot shown is the 
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Figure 4.13. Unfolding titration curve for wild type plus i31 TraI 309-858. Plot 
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Figure 4.14. Overlay of representative titration curves for all protein fragments. 
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Protein ∆GH20 (kcal/mol) m value 
WT TraI 309-858 4.87 ± 0.13 2.67 ± 0.04 
i369 TraI 309-858 4.84 ± 0.15 2.67 ± 0.05 
i593 TraI 309-858 4.83 ± 0.09 2.49 ± 0.01 
i681 TraI 309-858 4.6 ± 0.11 2.62 ± 0.02 
WT TraI + i31 309-858 4.70 ± 0.05 2.51 ± 0.25 
 
Table 4.3.  All of the calculated ∆G values are similar, indicating no change in the 
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To more clearly define what may be causing the altered baseline for i593, we 
performed a near UV scan of WT protein to determine if there is a near UV signal 
peak that could be used for monitoring a titration curve. Near UV CD can give 
information on the tertiary structure of the protein. By analyzing tertiary structure, we 
aimed to see if i593 was different from the other constructs in tertiary as well as 
secondary structure. WT TraI 309-858 was monitored at 100 µM concentration in a 1 
cm cuvette, and scanned from 250 nm to 350 nm. The resulting wavelength scan 
(Figure 4.15) did show a signal peak at 295 nm, but the signal strength was weak. To 
be able to monitor the titration curve of i593 in the near UV would require a five-fold 
increase in signal at 295 nm, meaning protein concentration of i593 would need to be 
quite high and potentially reach saturating concentrations. 
To get a more complete picture of the titration unfolding, the midpoint of the 
unfolding transition was calculated (Cm value, Table 4.4). The data was also plotted 
as ∆GH20 versus urea concentration using the following equation (2):  
∆G˚(x) = ∆GH20 + m(urea concentration) 
The Cm value for each construct is reported in Table 4.4. There are some differences 
in the Cm values between the WT construct, i593, i681, and WT+i31. Interestingly 
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Figure 4.15. The near UV scan of WT protein at 100 µM indicates a distinct signal 
peak at 295 nm. The peak signal maximum is small and monitoring at 295 nm would 
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Protein 
Fragment 





WT + i31 1.8725 
 
Table 4.4. The calculated midpoint of transition (Cm values). Values were calculated 
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The dependence of ∆GH20 on urea concentration was also plotted. The data for 
the calculated ∆GH20 versus urea concentration shows there are some differences in 
the trends for i593, i681, and WT+i31 (Figure 4.16). Interestingly there is almost no 
difference between i369 and WT. There may be some changes to i593 and i681 that 
do not occur in i369 due to where the i31 is in the protein. These results, along with 
the differences in the midpoint of transition, indicate the stability of the i593 and i681 
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Figure 4.16. Dependence of ∆G on urea molarity. The ∆GH2O values were calculated 
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The Stability of the TraI Fragments Discussion 
Initial analysis of the CD data for the 309-858 constructs did not show any 
noticeable large changes in ∆G values between the i31 constructs and WT. However, 
more in-depth analysis indicated there might be some changes in the i593 and i681 
constructs that could be contributing to the altered phenotype seen in the microscopy 
data. The ∆G values for the protein fragments did not show any major differences in 
the stability of the protein fragments. The changes in stability appear to be small 
differences, which could possibly account for the changes in mating efficiency.  
The protein fragment 309-858 contains 551 residues, and according to 
published values, should have m values in urea much larger than what they are 
(around 2.5 kcal/mol).A large data set of m values for proteins of varying sizes has 
been published, and can be used as reference for the m values calculated from the i31 
unfolding curves. The m value for a globular protein (pepsinogen) with 370 residues 
in urea is 7.8 kcal/mol. A protein with a similar m value to the 309-858 fragments is 
chymotrypsinogen A, which is only 245 residues long (Myers, Pace, and Scholtz, 
1995). Small m values would be an issue if some of the proteins had a small m value 
and others did not. That scenario would indicate titration unfolding was not capturing 
some of the unfolding of the proteins. However, the m values for all the fragments are 
small. Although they are not as large as other calculated values for similarly sized 
proteins, there is no difference between the m values, and they do not indicate any 
issues with the data collection.  
 We determined the midpoint of the unfolding transition (Cm) to more fully 
understand the data. The Cm value is calculated by dividing the slope of the line (∆G) 
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by the m value. The midpoint of transition, the denaturant concentration at which half 
the protein is unfolded and half is folded, is another indicator of protein stability. As 
reported in Table 4.4, there are some differences in the Cm values for the different 
fragments. The value for WT, 1.82 M, is close to the value for i369 at 1.81 M, while 
the values for the other constructs are changed versus WT. The Cm value for i681 
309-858 (1.75 M) is lower than the Cm value for WT, while the Cm value for i593 is 
not. 
The difference in the i593 Cm value could be due to the fragment having an 
altered baseline compared to the rest of the fragments and an altered wavelength scan. 
However, if the protein possesses more random coil structure, hypothetically the 
midpoint of transition should be lower (require less denaturant to unfold). Instead, the 
value was calculated to be 1.93 M, higher than that of WT. This result, indicating a 
change in stability, could be due to the m value of the protein. The m value of this 
protein is slightly smaller than the m values of any of the other fragments. The 
calculated m value of this protein fragment could be altering the Cm in such a way as 
to make the Cm value for this protein inaccurate.  
The Cm value for i681 is lower than that of WT by about 0.6 M. This shift in 
the midpoint does show there is a change in the stability of the protein. This change in 
stability could be a part of the effect the i31 insertion has on TraI at this position. The 
WT+i31 construct midpoint of transition is higher than that of WT, indicating that it 
is more stable than WT. However, the standard deviation in the calculated m value is 
much higher than that of the rest of the constructs. Like the i593 construct, the m 
value may not be completely accurate, and may not represent the full unfolding 
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transition of the protein. From the calculated Cm values, we can draw some limited 
conclusions due to potential issues with the m values. For the i681 fragment, more 
than likely the stability of the fragment is lower compared to WT; it has the lowest 
∆G value, and the lowest Cm value. The i369 fragment is close to WT in its ∆G and 
Cm values, and does not appear to show altered stability. The placement of the i31 in 
the i369 fragment may not result in altered stability due to the fact that the i31 is in a 
region of the protein that is disordered and has little structure.  
The dependence of ∆G on urea concentration of WT+i31 trends with i593 and 
i681. Like the Cm values, the equation used to calculate the dependence of ∆G on 
urea concentration uses the calculated m values. The WT+i31 data may not be 
accurate due to an m value with a large standard deviation, and the i593 data may be 
inaccurate due to unfolding of the protein. These data reinforce the conclusions from 
the Cm values of the proteins. The i681 fragment is not as stable as the WT fragment, 
and the i593 fragment possibly has altered stability, but due to other factors, this 
conclusion is not concrete.  
Finally, the concentrations of the protein fragments could have had an effect 
on the results of some of the unfolding curves. The wild type and i681 constructs 
purified at much higher concentrations than the rest of the constructs. After the last 
column, both WT and i681 had concentrations in the hundreds of micromolar range. 
This was much higher than the rest of the constructs, which purified in the tens of 
micromolar range (from 20-70 µM approximately). The samples could not be 
concentrated further, as the sample would have been too small for accurate pipetting. 
At this low of a concentration, determining an accurate concentration can be difficult. 
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The baseline of the WT+i31 construct (Figure 4.14) could be different because the 
concentration used for titration could have been slightly off from 2 µM (the 
concentration used in titration unfolding curves). Although the concentration could be 
responsible for the differences in the lower baseline signal, it should not affect the 
unfolding or the slope of the line. This merely explains the signal differences in the 
lower baseline.  
 
Alterations to the TSA in Full Length TraI Does Not Effect Mating Efficiency 
The change in the i31 mating efficiency data may not be due to changes in 
protein stability. There is recent evidence published in Redzej et al., 2013 that 
altering residues in the TSA of TraI can drastically change the translocation of the 
protein during mating. Residues in the TSA of TraI were mutated to determine if 
altering the TSA in the presence of the TSB would create a change in mating 
efficiency. There may be competition between the two domains for access to the pore 
coupling protein, and altering the binding specificity of one domain might create 
favorable conditions for faster access for the other domain. To test if altering the TSA 
changes mating efficiency, we created three different point mutants within the TSA.  
The first point mutant, A593V, was reported in Redzej et al., to reduce protein 
translocation to approximately 10% of wild type levels. We created this mutant in full 
length TraI, and ran mating assays with the TraI mutant. There was no noticeable 
change in mating efficiency in the A593V TraI mutant (Figure 4.17). We created a 
S739N TraI mutant, which reduced protein translocation to 20-30% of WT levels 
(Redzej et al., 2013). Again, we did not see any change in mating efficiency (Figure 
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4.17). We also created a D672N mutant, which was not created in the paper, but 
approximates the published mutations. We created this mutant since most of the 
mutations published were located around the i593 site. Identifying residues similar to 
the mutated residues around the i681 site, we chose D672 as it is a charged residue, 
and changing the charge might produce an effect like the previously identified 
translocation mutants. The D672N mutant does not show any difference in mating 
efficiency (Figure 4.17). None of the point mutants we created show any noticeable 
change in mating efficiency when compared to WT TraI.  
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Figure 4.17. Mating efficiencies (transconjugates per donor cell) of wild type TraI 
point mutants in the TSA region of the protein show no change versus wild type. 
Values represent the combination of at least three independent experiments for each 
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Changes to the TSA of TraI Discussion 
There was no change in mating efficiency seen in any of the point mutants 
that were created in the TSA of TraI. The mutants reported to have an effect on 
protein translocation were made in a fragment of R1 TraI, 1-992. These were also 
mutants that affect protein translocation, and the system that is used to measure 
protein translocation employs a fully functional copy of R1 TraI to ensure mating 
proceeds and protein can be translocated. In our assay TraI has a fully functional TSB 
and the small changes in the TSA may not be enough to elicit a change in mating 
efficiency. R1 and F may also not be completely equivalent, despite only having 2 
amino acid differences in the region of the crystal structure (Redzej et al., 2013). 
There may not be competition between the domains, as posited, in conjunction with a 
mutation that is quite small in the context of the whole protein. It may be necessary to 
mutate more residues in the TSA to create an effect similar to the i31. A single point 
mutation may not be enough of a change in the TSA to cause a change in mating 
efficiency.  
The avenue of investigation into the TSA of TraI playing a role in the i31 
phenotype did not show any changes in mating efficiency when the TSA was altered. 
However, the changes to the TSA of TraI were small compared to inserting 31 amino 
acids. Amino acid changes that cause mating efficiency to change may need to be 
more numerous to cause an effect. Possible further investigation could look at 
different length disruptions. Changing the i31 (i.e. making it shorter) and looking for 
changes in mating efficiency could be another avenue of investigation into the TSA 
region of TraI. Using this method, we could see if there is a dosage effect of 
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The i31 TraI mutants were analyzed by fluorescence microscopy mating and 
found to have DNA that appeared in recipient cells at earlier time points. 
Investigating this change, we determined the change seen was not due to factors in 
the recipient cell line, and we turned our lines of investigation to the donor cell. We 
used TraI fusion proteins, an activity assay, unfolding measurements, and TraI 
mutants to assess possible causes of the phenotype seen in the i31 mutants.  
Using the TraI-YFP point mutant constructs, we were trying to determine if 
changing stability of an inserted protein altered mating efficiency. We demonstrated 
that inserting the same protein with different stabilities changes mating efficiency. 
These data, while they indicate that altered protein stability can alter mating 
efficiency, are TraI fusion proteins. These are not measures of the stability of TraI 
itself or of TraI with the i31 insertion. These data do indicate protein stability is 
important in mating efficiency and more stable proteins hinder plasmid transfer while 
less stable proteins do not. These data show there is some degree of unfolding 
necessary for transfer, and the stability of proteins inserted into TraI can influence 
transfer.  
These data point to stability of TraI as a contributor to the i31 phenotype. It 
does not appear that the nicking activity contributes to the mating efficiency 
differences in the i31 mutants. Although the CD data do point to stability as being a 
potential explanation of part of the change in the mating efficiency of the i31 mutants, 
the data do not show any major changes in the stability of the protein. We had been 
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looking for a sizeable measurable change in protein stability of the i31 mutants, but 
the data do not show any large changes. However, we do see a small trend in the i681 
data that indicates it is less stable than WT, and a small change in stability could be 
part of the cause of the i31 mating efficiency increase. Thirty-one amino acids is not a 
large insertion (relative to the size of TraI), and the mutation may be causing local 
changes rather than global changes to stability. The work with the TSA point mutants 
did not show any changes in mating efficiency when residues in the TSA were altered. 
These residues had been implicated as being necessary contact points for the TSA to 
interact with the pore machinery (Redzej et al., 2013). When these contact residues 
were altered, protein translocation decreased, but with the TSB present, we did not 
see the same effect. 
The trend in the CD data, when correlated with the TraI-YFP point mutant 
data, makes an argument for protein stability playing a role in the TraI mutants. 
Although the YFP insertion data are mutations in a protein inserted into TraI, when 
taken together with the CD data, there are indications that altering protein stability 
causing changes in mating efficiency. The data also indicate the i31 mutants may 
have positional effects and one overall model does not explain the effect of the i31 at 
each site. The microscopy data, in concert with the TraI-YFP and CD data all indicate 
the effects at i593 and i681 may be due to stability, but the effects of the i31 at i369 is 
probably due to a different cause. Overall, the data presented here demonstrate the i31 
mutants with increased mating efficiencies show an increased rate of DNA transfer, 
and the increase could be partially explained by changes in the stability of the protein.  
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